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Abstract 
Introduction: This dissertation is focused on the metabolomic and transcriptomic 
changes that occur as a result of carbohydrate prefeeding during hemorrhagic shock and 
trauma within the liver of a porcine model.  The risk of trauma and hemorrhagic shock 
continues to be an important issue in both military and civilian sectors.  As such, we 
explored the impact of a prior fed state upon the overall response to hemorrhagic shock 
and resuscitation.  The primary hypotheses were that changes in metabolism at the 
metabolomic and transcriptomic levels would be dependent upon the fed state.  In 
addition, this thesis explores a more comprehensive analysis of metabolomics datasets to 
standardize analysis and improve overall consistency. 
Materials and Methods: Algorithm comparison was accomplished using six commonly 
applied methods to three synthetic datasets, of different sample sizes, and three openly 
accessible published datasets.  This comparison also incorporated metrics to measure 
consistency of identified features (i.e. stability) to provide further confidence in results.  
Metabolomics analysis was accomplished with nuclear magnetic resonance spectroscopy 
(NMR) and Chenomx software to profile and quantify metabolites in liver extracts.  The 
metabolome was subsequently analyzed with partial least squares discriminant analysis 
(PLS-DA).  Transcriptomics analysis was conducted using next-generation sequencing 
(NGS) technology to employ RNA-sequencing (RNA-seq) on mRNA extracts from liver 
biopsies.  The RNA-seq data was analyzed using typical processing techniques to 
generate a count matrix and subsequently analyzed with the Bioconductor package 
EdgeR. 
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Results: The comparison of algorithms showed that the best algorithm is associated with 
differently structured datasets (e.g. number of features, number of groups, sample size, 
etc.).  Analysis of the liver metabolome revealed changes in carbon energy sources, 
amino acid metabolism, oxidative stress, and membrane maintenance.  Transcriptomic 
analysis revealed changes in carbohydrate metabolism, cytokine inflammation, 
cholesterol synthesis and apoptosis.  In addition, there is evidence of increased 
cytoskeleton reorganization which may correspond to a shrunken, catabolic state which 
provides and anti-inflammatory condition to mitigate cellular damage. 
Conclusion: The response to hemorrhagic shock and resuscitation is altered with respect 
to a fasted or carbohydrate prefed state.  Metabolomics and transcriptomic analyses 
suggest altered metabolic pathways as a result of fed state.  Altered carbohydrate 
metabolism was readily identified thereby confirming both methods were successful.  
Additionally, indications of membrane maintenance that follow cytoskeletal remodeling 
and cellular shrinkage are potentially reflected by 3-Hydroxyisovalerate and sn-Glycero-
3-phosphocholine.  These results provide further evidence for pre-conditioning (e.g. 
altered diet) and hypertonic resuscitation methods to possibly improve patient outcome.  
Further research is required in alternative prefeeding substrates (e.g. protein, lipid, etc.) 
as well as improving the integration of different systems level datasets to understand 
more thoroughly the systemic effects of hemorrhagic shock and resuscitation. 
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I. INTRODUCTION 
 
Hemorrhagic shock and traumatic injury information 
Worldwide, trauma is a leading cause of death for those between 5 and 45 years 
irrespective of demographics
1,2
.  Of these deaths, up to 50% are due to hemorrhagic 
shock.  Patients injured during active military duty are also commonly admitted with 
hemorrhagic injuries
3
.  Furthermore, survival of the initial insult can lead to further 
complications including multiple organ dysfunction syndrome (MODS), which remains a 
predominant cause of late deaths
4
.  Although treatments have improved and trauma care 
has continued to keep pace with an aging population, the overall survival of trauma 
patients remains constant
5
.   
Briefly, hemorrhagic shock is a life-threatening condition resulting from 
inadequate tissue perfusion, followed by activation of the inflammatory cascade and 
changes in metabolic processes.  The reduced blood flow to peripheral tissues results in 
hypoxia and subsequent reperfusion injury
6
.  This decreased volume and available 
oxygen leads to an extensive metabolic cascade.  In brief, the lack of oxygen slows/stops 
oxidative phosphorylation via the electron transport chain and shifts the cells a glycolytic 
state
7
.  Without oxygen as the final electron acceptor, the mitochondria balance 
membrane potential via reversal of ATP synthase thereby using ATP to translocate 
protons across the inner membrane
8
.  This decrease in ATP leads to conversion of 
adenine nucleotides to hypoxanthine and xanthine, substrates for xanthine oxidase which 
serves as another ROS generator
9,10
.  Inflammatory pathways are also activated which are 
promoted by inducible nitric oxide synthase (iNOS).  Furthermore, the large amounts of 
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oxygen returned upon resuscitation result in further ROS via enzymes such as NADPH 
oxidase
11
 and tissue reperfusion damage. 
Metabolic component of hemorrhagic shock 
There are many systemic changes in response to hemorrhagic shock; however, 
this dissertation focuses on the metabolic response of the liver.  The inadequate tissue 
perfusion following hemorrhagic shock leads to decreased oxygen availability to the 
mitochondria resulting in a switch towards anaerobic metabolism.  The liver serves an 
important function as a regulator of metabolism during stressed states.  Initially, the shift 
towards anaerobic metabolism stimulates the liver to increase glycogenolysis and process 
elevated lactate produced in the peripheral tissues.  The liver also provides a major site of 
detoxification and production of alternate metabolic fuel sources including amino acids 
and lipids.   
Of particular interest, the impact of fed state on the hepatic response to 
hemorrhagic shock is evaluated.  Previously, the effect of different fed states on liver 
metabolic processes following injury and hemorrhagic shock were not well known.  To 
elucidate these processes a systems level analysis via metabolomics and transcriptomics 
provide a broad exploration of potential responses. 
Metabolomics  
Metabolomics, briefly defined, is a study of all the low molecular weight 
metabolites that collectively make up the metabolome.  This technique allows a 
comprehensive analysis of the changes within the metabolome and their respective 
correlations with a physiologic response
12
.  One commonly used technique is via nuclear 
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magnetic resonance spectroscopy (NMR) and has been successfully applied towards 
studies of a diverse set of medical studies including pancreatitis, cancer, and diabetes
13,14
.   
Transcriptomics 
Transcriptomics is the study of all the RNA that collectively makes up the 
transcriptome.  The transcriptome provides a global analysis of the biochemical state of 
the organism.  In contrast to metabolomics which provides a picture of the metabolic end 
products, transcriptomics presents what the metabolic response is able to do.  The 
expressed RNA corresponds to proteins that may be actively translated to express a 
particular phenotype of biochemical pathway.  In this manner, one can evaluate the 
‘state’ of the organism at a given time or condition. 
The application of metabolomics and transcriptomics to the study of hemorrhagic 
shock may provide novel insights into the complex metabolic responses that can direct 
future efforts to improve quality of care and reduced mortality. 
Purpose of the dissertation 
 This dissertation focuses on the systems level analysis of the hepatic response to 
hemorrhagic shock and trauma.  It is composed of four chapters of background material 
and three chapters of experimental results.  The second chapter provides information 
regarding known physiologic and metabolic responses of hemorrhagic shock.  As the 
primary focus of this dissertation is on the liver it is addressed in Chapter 3.  Chapters 4 
and 5 provide concise overviews of metabolomics and transcriptomics including common 
methods and analyses.  Given the lack of an objective means to determine the most 
appropriate method to analyze metabolomics data, the first study presented in Chapter 6 
consists of the development of a program to apply systematically multiple accepted 
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methods for the analysis of metabolomics data sets and evaluate performance and 
stability of algorithm performance.  Chapter 7 presents the analysis of the liver 
metabolome in response to hemorrhagic shock and trauma.  Although any ‘omics’ level 
analysis is powerful, each is inherently limited to its position in the biological cascade 
from genes to metabolites.  To acquire a more holistic perspective a transcriptomic 
analysis is subsequently provided in Chapter 8.  In conclusion, Chapter 9 provides an 
initial integration of these two levels of biological expression followed by suggested 
future directions.  
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CHAPTER 2 
 
Hemorrhagic Shock 
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Introduction 
 Hemorrhagic shock often follows traumatic injury characterized by inadequate 
perfusion leading to hypovolemic and hypoxic conditions.  This results in several 
complex metabolic and physiologic processes that take place systemically to help the 
body recover.  This chapter will consist of a brief overview of these metabolic and 
physiologic changes. 
In response to acute hypovolemia, multiple endocrine compounds are released 
including glucagon, cortisol and adrenocorticotropic hormone (ACTH).  In order to 
maintain normal blood pressure angiotensin II and vasopressin are also released to elicit 
vasoconstriction and decrease fluid excretion.  As a consequence of reduced blood flow 
and vasoconstriction, tissues begin to experience hypoxia and must convert to anaerobic 
energy states.  Glucagon helps to provide the increased glucose demand of anaerobic 
glycolysis by inducing hyperglycemia via hepatic glycogenolysis.  However, if the 
duration of shock is extended the glycogen stores become depleted resulting in a 
subsequent hypoglycemic state leading to mitochondrial dysfunction and overall 
decompensation. 
In an effort to restore circulation, reperfusion methods are employed using 
crystalloids (often first choice), colloids, hypertonic saline, and blood transfusions.  
However, this effort to reestablish blood flow and oxygen supply enhances injury and 
aggravates damage at cellular level commonly referred to as ischemia-reperfusion injury.  
Injured cells remain in the hypoxic state and may be unable to restore fully functional 
mitochondria.  This hypoxic condition stimulates the transcription factor nuclear factor 
kappa beta (NF-κB).  Once released from the inhibitory protein IκB, NF-κB translocates 
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to the nucleus where it stimulates production of pro-inflammatory cytokines (e.g. TNF-α, 
IL-1β, and IL-6), chemokines and adhesion molecules15.  Evidence suggests that the pro-
inflammatory cytokines, reactive oxygen species, and deranged Ca
2+
 homeostasis elicits 
cell death.  The mechanism of cell death however is also up for debate as indication of 
necrosis and apoptosis are present. In response, a combination theory was developed 
called “necrapoptosis” whereby there are common mechanisms that lead to both forms of 
cell death
16
. 
Ischemia-reperfusion has been extensively studied over the years with many 
improvements in treatment that are applicable to hemorrhagic shock.  One particular 
discovery that has not yet found application is pre-conditioning.  Pre-conditioning is the 
process whereby an organ is exposed to short periods of ischemia.  The applications are 
more easily seen in liver surgery and transplants but not directly applicable for trauma 
induced hemorrhagic shock.  However, this suggests that organs may be stimulated into a 
state that is more prepared to survive a hypoxic episode.  One way this pre-conditioning 
may be administered is a different fed state as characterized by previous studies that 
suggest increased carbohydrates improves survival in rats
17
.  However, recent evidence 
has shown that mouse models poorly mimic human trauma, burns and endotoxemia
18
.  As 
such, the following investigations focus on a porcine model of trauma and hemorrhagic 
shock to reflect more accurately the human response.  
Animal Preparation  
All of our experiments have the same preparation and administration of the shock 
protocol (Appendix A). The experimental protocol was approved by the University of 
Minnesota Animal Use Committee and was conducted in accordance with established 
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guidelines for the treatment of laboratory animals. Male Yorkshire-crossbreed pigs 
(Manthei Hog Farm, LLC, Elk River, MN) weighing 15-20 kg were fasted overnight 
prior to surgery but are allowed water ad libitum.  Two experimental groups were 
utilized: Carbohydrate Prefed (CPF, n = 32) and Fasted (FS, n = 32).  CPF animals were 
given 7cc/kg bolus of Karo Syrup
®
 (mixture of sugars including ~ 15% glucose, maltose, 
fructose and sucrose) diluted with water 1 hour prior to induction of anesthesia.   
The animals were then anesthetized with an intramuscular dose of telazol (Wyeth 
Animal Health, Madison, NJ).  Anesthesia was maintained by an i.v. infusion of propofol 
(2-9 mg/kg, AstraZeneca Pharmaceuticals, Wilmington, England ) and 60% inhaled 
nitrous oxide throughout the experiment. Upon sedation, the pigs were orally intubated 
and ventilated (Servo 900, Siemens-Alema AB, Sweden) to maintain a PO2 of 70-120 
torr and a PCO2 of 35-45 torr (SERVO Ventilator 900C, Siemens, Malvern, PA). 
Peripheral intravenous lines were placed in the surgically exposed right femoral artery 
and right jugular vein. A catheter was placed in the right femoral artery for continuous 
measurement of blood pressure and blood sampling. An introducer (7 French Avanti, 
Cordis Corporation, Miami Lakes, FL) was placed into the right jugular vein and a Swan-
Ganz catheter (5 French, Edwards Lifesciences, Irvine, CA) was placed for 
measurements. To evaluate the status of the animal, we monitored pulmonary artery 
pressure, pulmonary wedge pressure, cardiac output, and mixed arterial blood sampling. 
The measurements are useful in gauging the extent of and severity of the hemorrhage. 
Animals underwent a midline laparotomy, splenectomy, and a Foley catheter was placed 
in the urinary bladder via stab cystostomy.  Under stressful conditions, the spleen is 
capable of contracting, releasing stored blood, and changing the intravascular volume. 
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Because the spleen can sequester 22% of the circulating red cell volume and a similar 
amount of plasma
19
, a splenectomy is imperative to minimize the effect that the spleen 
has on hemostasis. The inferior vena cava (IVC) was cannulated for the controlled 
hemorrhage. After surgical preparation the animals entered a stabilization period until 
plasma lactate levels reach a value of 2.0 mmol/L or less (Instrumentation Laboratory 
Co., Lexington, ME).  
Polytrauma  
As most cases of hemorrhagic shock are caused by trauma we chose to utilize a 
model of polytrauma.  Upon stabilization from surgical preparation, the animals undergo 
a simulated pulmonary contusion from a captive bolt device to create a blunt percussive 
injury.  Hemorrhagic shock was induced by removal of blood via IVC catheter into acid-
citrate-dextrose (ACD) blood bags to obtain a systolic blood pressure (SBP) of 45 to 
55mm Hg (typically ~40% of total blood volume). A liver crush injury was induced using 
a modified Holcomb clamp technique
20
 in the liver parenchyma.  
Resuscitation:  
 Fluid therapy is ideally administered as soon as possible to compensate for 
hypovolemia.  However, certain situations do not facilitate immediate full resuscitation 
such as injuries suffered by soldiers.  A limited resuscitation can be administered during 
transportation to additional medical assistance.  To simulate such a situation, after 45 
minutes of shock animals received lactated Ringer’s fluid given as 20 cc/kg intravenous 
(IV) boluses to maintain a systolic blood pressure greater than 80 mmHg for one hour of 
limited resuscitation.  Afterwards the animals underwent a full resuscitation protocol for 
the following 24 hours. This resuscitation included fluid, shed blood, and ventilator 
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support in a protocolized fashion.  Animals were resuscitated to standard clinical 
endpoints of systolic blood pressure (90 mmHg), urine output (1 cm3/kg/h), and 
hemoglobin (≥6 g/dL) for 20 h.  Throughout the shock and resuscitation periods, animals 
are maintained on the ventilator and received an adjusted-dose of propofol and nitrous 
oxide to maintain an appropriate level of sedation and comfort as evaluated by clinical 
examination and a bispectral index (BIS) monitor.  After the resuscitation period, 
surviving animals were extubated and sent to recovery and subsequently euthanized. 
Sample Collection 
At several time points throughout the experiment, liver biopsies were taken from 
the periphery of the liver ranging in weight from 0.2 to 0.6 grams.  Biopsies were flash 
frozen in liquid nitrogen and stored at -80°C until preparation for further analysis.  
Biopsies were taken at the following timepoints: baseline after the animal stabilized from 
instrumentation (B), 45 minutes after hemorrhage (S45), 2, 8, and 20 hours after full 
resuscitation (FR2, FR8, FR20).  This full protocol is presented diagrammatically in 
Appendix A.  In this manner, an overall response including prior to and throughout the 
insult would be measured. 
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CHAPTER 3 
 
The Liver 
  
12 
 
Introduction 
 In Chapter 2, the physiologic and metabolic responses to hemorrhagic shock were 
discussed in a systemic context.  The majority of this dissertation focuses on metabolites 
and genes expressed in the liver.  As such, this chapter will provide a general overview of 
the response of liver to hemorrhagic shock and trauma.  The liver is a complex organ 
with a wide range of functions that are critical for survival.  To date the numerous and 
intricate functions of the liver cannot be replicated for any definite length of time in the 
event of liver failure.  To my knowledge, there are no major differences between human 
and porcine liver beyond the number of lobes (humans = 4, pigs = 5).  As such, this 
chapter and subsequent discussions assume the porcine liver displays the same functions 
and metabolic pathways as humans. 
 Both lipid synthesis and degradation processes take place in the liver.  This 
includes cholesterol synthesis, lipogenesis and lipoprotein production.  Bile salts are also 
produced via CYPs-mediated oxidation of cholesterol.  These bile salts are an important 
component of bile to help emulsify lipids and fat-soluble vitamins (e.g. Vitamin K) for 
digestion.  Most of the synthesized bile is stored in the gall bladder for later use.  
Among the most well studied and important functions of the liver is glucose 
regulation.  When glucose levels are high and the body does not require further energy 
production, glucose is typically converting into glycogen.  The liver serves as the primary 
glucose reservoir for most peripheral tissues and likewise a primary location for 
glycogenolysis and gluconeogenesis during periods of starvation or physiologic stress.  
The regulation of these processes consists of multiple different stimuli.  Glycogenic 
stimuli include insulin, glucocorticoids, parasympathetic impulses and gluconeogenic 
precursors (e.g. fructose, amino acids).  Glycogenolysis is primarily regulated by 
13 
 
glucagon, noroadrenaline and ATP but also stimulated by adenosine, nucleotides and 
nitric oxide 
21
. 
Detoxification of both endogenous molecules (e.g. ammonia, steroid hormones) 
and exogenous compounds (i.e. antibiotics) is perhaps one of the most important 
functions of the liver.  The process of detoxification is typically described in two phases 
known as “Transformation/Modification” and “Conjugation”22; however a third phase is 
added known as “Transport”.  In essence, the enzymes of phase I, mostly of the 
cytochrome P450 (CYPs) family, begin detoxification of lipid soluble compounds by 
converting them into water soluble forms for phase II detoxification. These CYPs require 
oxygen in order to function resulting in ROS byproducts.  These free radicals are 
mediated by antioxidants such as glutathione and vitamin C; however, excessive 
production can damage liver cells.  This response may also be dependent upon diet as 
alternate diets in mice have shown an altered antioxidant response in the liver
23
.  Phase II 
enzymes further increase solubility and decrease toxicity by conjugating a secondary 
molecule.  Unlike phase I, phase II enzymes consist of several families including UDP-
glucouronlytransferases (UGTs), Glutathione S-transferases (GSTs), Sulfotransferases 
(SULTs) and amino acid conjugating enzymes
24
.  Phase III enzymes consist of 
transporters belonging to the ABC transporter family.  Once the toxin conjugates have 
been formed these transporters move them into the bile for excretion
25
. 
Response to Hemorrhagic Shock and Resuscitation 
 Hemorrhagic shock induces the release of glucagon, catecholamines and 
glucocorticoids which rapidly increase liver glycogenolysis and gluconeogenesis causing 
hyperglycemia.  This is typical of many other forms of trauma including sepsis and burns 
14 
 
where energy expenditure is increased resulting in a hypermetabolic state.  The 
hyperglycemic state is followed by a rapid increase in insulin to absorb the available 
glucose in peripheral tissues as well as suppress hepatic gluconeogenesis and 
glycogenolysis.  However, both peripheral tissues and the liver develop insulin resistance 
which contributes to extended hyperglycemia.  Although the mechanisms for insulin 
resistance are not fully understood, evidence suggests altered insulin regulating pathways 
such as the PI3-kinase-Akt pathway
26
.  This hyperglycemic state does abate during late 
stages of shock when hepatic glycogen is exhausted leading to a subsequent 
hypoglycemic state
27
. 
 In addition to altered glucose regulation, evidence suggests a relationship between 
mitochondrial dysfunction is common following trauma and hemorrhagic shock
28
 and 
correlated with irreversible pathologic damage
29–31
.  Decreased hepatic mitochondrial 
function results in decreased ATP and subsequently increased degradation products. 
These degradation products require removal and may overwhelm the capacity of the 
hypoxic liver resulting in liver failure and toxin buildup.  Treatments such as the addition 
of pyruvate and antioxidants have been suggested as methods to improve outcome
32–34
.  
In addition, previous studies have suggested the use of insulin and glucose may improve 
outcome in rats
35
 however there are no studies that apply this induced carbohydrate state 
in larger mammals.  This is explored in Chapters 7 and 8. 
Several pathways exist to generate ROS which under normal conditions are 
mediated by endogenous mechanisms.  However, ischemia-reperfusion injuries can result 
in ROS levels that exceeds the liver capacity by stimulation of Kupffer cells, the primary 
source of vascular reactive oxygen species during the reperfusion period
36
.  Furthermore, 
15 
 
macrophages, which facilitate removal of apoptotic bodies, and pro-inflammatory 
cytokines (e.g. TNF-α, IL-1, interferon-γ) also generate and induce more ROS 
respectively
37,38
.  As a result, antioxidant strategies have been pursued to address the 
oxygen stress of hepatocytes.  These studies have included stimulation of increased 
glutathione, superoxide dismutase and heat shock proteins in ischemia-reperfusion 
models
39
.  Strategies to remove the inflammatory oxidant stress via depletion of Kupffer 
cells has also been shown to effective
40
. 
 Despite the advancements in understanding the molecular mechanisms of the liver 
following ischemia and reperfusion much is left to be discovered.  Furthermore, most of 
the previous research has been applied to small animal models which may not accurately 
reflect human physiology.  Of interest herein, there have been few investigations on the 
impact of diet on the response of the liver to hemorrhagic shock and trauma.  To explore 
this question, two systems level approaches, metabolomics (Chapter 4) and 
transcriptomics (Chapter 5), will be employed to acquire a more holistic picture of 
potentially altered metabolic pathways. 
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CHAPTER 4 
 
The Metabolomics Process 
17 
 
Introduction 
 The complex metabolic changes and the physiology of the liver were discussed in 
the previous chapter.  In this chapter, it will be presented that metabolomics provides an 
ideal tool towards investigating the hepatic response to hemorrhagic shock and the impact 
of a carbohydrate fed state.  This chapter will provide a concise overview of the field of 
metabolomics and how one can identify and quantify metabolites from collected tissues.  
This method will be applied to the porcine hemorrhagic shock and traumatic injury in 
Chapter 7. 
In essence, the objective of any ‘omic’ science is the global, non-targeted 
quantification of the biomolecules comprising a particular level of organization from cell 
and tissue, to an entire organism. This effort initially began with identifying the genetic 
structure of organisms (genomics) and subsequently identifying the corresponding gene 
transcripts (transcriptomics – Chapter 5). The study of the translated protein products has 
also continued to be developed with potential for post-translational modifications.  In the 
end, the molecular cascade leads to the regulation of small molecule metabolites. The 
high-throughput profiling of all of these metabolites within a single sample constitutes 
the study of metabolomics
12
. The quantitative analysis of a large array of metabolic 
constituents (metabolome) provides a holistic, or ‘systems level’, view of the biochemical 
state of an organism. This potentially allows for the exploration of altered metabolic 
pathways within a given physiologic state.  This makes metabolomics an ideal method for 
exploring the complex changes elicited by hemorrhagic shock and trauma.   
Metabolomic experiments utilize various analytical methods such as gas or liquid 
chromatography, mass spectrometry (MS), or nuclear magnetic resonance spectroscopy 
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(NMR). Each of these methods separately or in combination is capable of quantifying 
metabolites in biological samples. While each method possesses advantages and 
disadvantages, the ultimate product is an extremely large and complex dataset wherein 
the number of features (e.g. metabolites) often far outnumbers the samples.  These types 
of datasets are commonly referred to as ‘high-dimensional’.  These datasets require the 
use of multivariate analysis techniques such as partial least squares discriminant analysis 
(PLSDA) and random forest (RF).  Despite the availability of such methods, there is 
currently no recommendation on when to use which method.  This problem will be 
addressed in Chapter 6. 
Our metabolomics experiment utilizes 1H-NMR and was designed to evaluate if a 
carbohydrate fed state alters the hepatic response to hemorrhagic shock and trauma.  This 
subsequently allows an insight into metabolic processes, as a consequence of a fed state, 
that are associated with hemorrhagic shock and its complications. This chapter discusses 
the overall metabolomic process including NMR, metabolite quantification, and 
statistical analysis.  
NMR Metabolomics 
Proton NMR spectroscopy is particularly well suited for untargeted metabolomic 
analysis as the large number of small molecules (100’s to 1000’s) within a biological 
sample can be quantified simultaneously
12
. NMR spectroscopy has be used successfully 
to analyze the metabolome of multiple biofluids and tissues including urine
13,41,42
, 
serum
43,44
, and tissue extracts
45,46
.  Additionally, with advances in solid state NMR 
analysis, metabolomics is now being applied on intact tissues to study various medical 
problems including breast cancer
47
, skeletal muscle disease
48,49
 and pancreatic cancer
50,51
. 
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While mass spectrometry (MS) is known to be more sensitive than NMR 
spectroscopy
52,53
, NMR is an accepted metabolomics platform with some distinct 
advantages over MS.  NMR can be more cost-effective and easier to automate than MS, 
making it preferable for high-throughput studies
53
. The required sample preparation for 
MS analysis can cause metabolite loss, while NMR can measure intact biological samples 
in both liquid and solid states with minimal sample preparation. Finally, NMR is non-
selective and capable of simultaneously detecting a wide range of small molecules, 
whereas MS may require more than one sample preparation or platform to cover the 
range of small molecules in a biological sample
52,54,55
.  
Sample collection and preparation 
The first step to quality NMR acquisition is proper sample collection. In our 
experiments, liver is the tissue of choice and the remainder of the chapter will be focused 
tissue metabolite extraction. Immediately after collection, the degradation process has 
begun.  It is imperative to slow the tissue degradation process as much as possible to get 
an accurate picture of the metabolic state.  Tissue biopsies are typically flash frozen in 
liquid nitrogen and stored at -80°C until future metabolite extraction. 
There are also multiple metabolite extraction techniques each with advantages and 
disadvantages as well as target metabolite group
45
.  The specific method chosen is 
dependent upon the goals of the experiment (e.g. profile as many metabolites as possible, 
extract only hydrophobic metabolites, etc.).  Once a method has been decided, the precise 
and consistent handling of the tissue is important to yield the most consistent and clear 
spectra. Multiple factors may affect the quality of the NMR spectra including the pH, 
salinity, temperature, and concentration of metal ions in the sample.  These changes 
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affect the sensitivity of NMR, reduce the quality of data, and increase the time required to 
identify and quantify the chemical signatures in the spectra.   
NMR spectroscopy theory 
 NMR is based upon exploiting the inherent magnetic properties of nuclear 
particles.  By placing the nuclei in a strong magnetic field the orientation is fixed along 
the same axis as the applied field.  These nuclei are then pulsed with a radio frequency of 
the same frequency as the specific nuclei precession (i.e. rotation rate about the axis).  
This causes the magnetization vector of the nuclei to turn orthogonal to the primary axis.  
Because of the constant magnetic field the nuclei begin to transition back towards 
primary axis while continuing to precess.  This results in the magnetic vector spiraling 
around the primary axis thereby inducing an electrical signal that is received by the radio 
frequency coils to be subsequently interpreted by a computer resulting in the observed 
spectra (Figure 1). 
 
Figure 1 – Representative 1H-NMR spectra 
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 Each of the elemental nuclei possesses its own resonant frequency determined by 
the applied magnetic field of the NMR.  This resonant frequency may be further modified 
by other surrounding nuclei which alter the magnetic field applied (i.e. shielding).  This is 
what allows different compounds to possess different resonant frequencies.  To interpret 
these frequencies, the chemical shift of a compound is calculated as a reference to a 
known internal standard.  The chemical shift, in parts per million (ppm), is set at 0 for the 
internal standard.  The observed chemical shift varies between compounds facilitating 
identification (i.e. compound fingerprinting).  In this manner, many different molecules 
can be identified simultaneously without bias, provided the compounds all contain the 
specific nuclei being analyzed (e.g.
`1
H, 
13
C, etc.).  This provides an advantage of mass 
spectrometry whereby different ionization properties of compounds can affect detection 
and quantification. 
Quantification 
Several techniques are utilized to preprocess the data in preparation for large 
statistical analysis. With raw NMR spectra it is necessary to align, phase and correct the 
baseline in order to optimize the spectra for accurate quantification of the NMR chemical 
signals.  An internal standard of known concentration must also have been added to the 
sample prior to NMR acquisition.  The resulting preprocessed spectra are then imported 
in Chenomx NMR Suite 7.5 (Alberta, Canada). Once imported, Chenomx can conduct 
multiple types of analysis including binning and targeted profiling on the imported 
spectra
56
. We elected to utilize targeted profiling which quantifies individual metabolites 
relative to the internal standard (Figure 2). Compound identifications are based on the 
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human metabolome database (HMDB), spiking experiments, published literature, and 
Chenomx NMR suite version 7.5 chemical signatures.  
 
Figure 2 – Example of quantitative profiling a peak with Chemomx. 
Statistical Analysis 
Data Pre-treatment  
Biochemical processes have a large amount of variation.  Some changes may need 
to be very large to elicit a response whereas small changes may also result in physiologic 
changes.  To account for these variations, data pre-treatment can be used to adjust the 
data to emphasize the important biological implications. One common pre-treatment 
method to accomplish this is scaling the data.  In our experiments we utilize the 
Autoscaling method (i.e. unit variance scaling) which gives equal importance to all 
metabolites despite several orders of magnitude difference in their concentrations. There 
are other scaling methods such as Pareto and Vast but the Autoscaling method has been 
shown to perform better for explorative analyses
57
. 
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Data Analysis  
There are many ways to analyze metabolomics datasets including univariate and 
multivariate statistical techniques. Univariate analyses may be conducted with t-tests, 
analysis of variance (ANOVA), and/or regression.  However, repeatedly applying a 
univariate test rapidly increases the Type I error rate leading to potential false positives.  
Corrections such as Bonferroni and Benjamini-Hochberg False Discovery Rate decrease 
Type I error but also increase Type II errors increasing the risk of overlooking 
information.  Multivariate statistics, on the other hand, were developed to analyze 
multiple variables simultaneously thereby omitting the need for subsequent corrections.  
Multivariate methods are diverse and the field continues to develop alongside the 
expansion of ‘omics’ investigations.  As a consequence, there are several methods that 
are utilized by different labs.  Among the most commonly used methods are partial least 
squares discriminant analysis (PLSDA), random forest (RF), gradient boosting machines 
(GBM), support vector machines (SVM), regularized generalized linear models 
(GLMNET), and predication analysis of microarrays (PAM).  Collectively, these are 
‘supervised’ methods, wherein the classification information (e.g. treatment, control, etc.) 
is incorporated into the development of the classification model.  Although each method 
is an effective classification algorithm previous comparisons of algorithms in gene 
expression experiments report that different algorithms provide improved accuracy
58
.  
However, an extrapolation of these prior conclusions to metabolomics data would be 
premature as there is no single method that is established to evaluate algorithms applied 
to metabolomics data. This problem is addressed in Chapter 6 with the development of a 
novel, open-source program for the systematic comparison of algorithm performance. 
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CHAPTER 5 
 
The Transcriptomics Process 
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Introduction 
The complex metabolic changes and the physiology of the liver and the potential 
application of metabolomics have been discussed in the prior chapter.  In this chapter, it 
will be presented that transcriptomics provides another excellent tool towards 
investigating the impact of a carbohydrate fed state on the hepatic response to 
hemorrhagic shock.  This chapter will discuss the field of transcriptomics, experimental 
design and bioinformatics analysis.  This method will be applied to the porcine 
hemorrhagic shock and traumatic injury model in Chapter 8. 
 Transcriptomics experiments utilize either microarrays or next generation 
sequencers. Each of these methods is capable of quantifying RNA transcripts in 
biological samples; however, microarrays are beginning to be replaced by RNA-
sequencing (RNA-seq) for multiple reasons.  Microarrays require a genomic sequence of 
the organisms and the transcripts to be physically plated.  Although high-throughput, this 
has several limitations including a need for higher amounts of purified RNA, limited 
ability to distinguish between isoforms, and high background noise.  Furthermore, the 
expression level determined by RNA-seq of each RNA unit is measured by the number of 
sequenced fragments that map to the transcript, which is expected to correlate directly 
with its abundance level.  As a consequence, the expression signal of a transcript 
measured by RNA-seq is limited by the sequencing depth and is dependent on the 
expression levels of other transcripts in contrast to microarrays probe intensities which 
are independent of each other
59
.  This, as well as other technical differences, has 
motivated a growing number of statistical algorithms that implement a variety of 
approaches for normalization and differential expression (DE) detection
60
. 
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Next generation sequencing (NGS) technology improvements and reduced costs 
has facilitated the analysis of gene expression levels and is currently being applied to 
complex medical investigations such as Alzheimer’s Diesease61.  RNA-seq is a powerful 
method whereby the identification of gene isoforms, translocation events, nucleotide 
variations and post transcriptional base modifications become possible in a high-
throughput manner
59
.  This potentially allows for the exploration of altered physiologic 
pathways within a given pathologic state.  This makes transcriptomics a powerful 
technique for exploring the complex changes elicited by hemorrhagic shock and trauma.   
These ‘high-dimensional’ datasets require further processing in order to use the 
RNA sequence reads.  If the model organism has a sequenced genome the reads may be 
aligned and mapped to a reference genome otherwise the reads must be assembled de 
novo.  Once the reads have been identified subsequent multivariate analysis can be 
applied for DE.  There are multiple different tools to analyze these datasets including 
commercial and open-source that are continually being improved and compared
60,62,63
.  
Among the most commonly used is the open-source edgeR bioconductor package
64
.  This 
package uses empirical Bayes estimation and exact tests based on the negative binomial 
distribution, which has been shown to best approximate RNA-seq distributions.  It also 
has the capacity to create design matrices to incorporate multiple factors including time 
into the model. 
Transcriptomics via RNA-sequencing 
RNA Sequencing Platforms 
 At the start of an RNA-seq experiment a sequencing platform must be selected.  
There are several next generation sequences (NGS) available
65
.  Most platforms now use 
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sequencing-by-synthesis technology but differ in the use of a polymerase or ligase.  
Platforms also differ by either sequencing single molecules or multiple identical copies of 
a molecule (i.e. ensemble).  Single molecule sequencing (SMS) platforms avoid the 
amplification via PCR thereby providing a direct reflection of RNA expression but 
possess an inherently high error rate.  The non-SMS platforms, such as Illumina and 
SOLiD, have a very low sequencing error rate but have higher numbers of mismatches.  
Additionally, non-SMS platforms offer increased ‘sequencing depth’ thereby facilitating 
detection of low expressed transcripts
66
.   
These different platforms provide data that varies and changes how it can be 
interpreted.  Reads generated must be assembled in order to identify transcripts.  Longer 
reads facilitate accurate assembly.  Roche 454 and PacBio provide long reads (>500 nt), 
however, the paired end sequencing provided by Illumina allows increased nucleotide 
length as well (few hundred nt)
66
.  For our experiments, we have selected the Illumina 
platform utilizing the paired end sequencing.  This provided a trade-off wherein a very 
low error rate could be maintained while having medium length reads relative to long 
reads of Roche 454 and PacBio.  This facilitates the exploratory nature of our experiment 
to investigate possible perturbations to hemorrhagic shock as a result of fed state.  The 
remainder of this section will focus on preparation for the Illumina platform.   
Sample Preparation 
The first step to quality RNA-sequencing is proper sample collection. In our 
experiments, liver is the tissue of choice and the remainder of the chapter will be focused 
tissue metabolite extraction. Immediately after collection, the degradation process has 
begun.  It is imperative to slow the tissue degradation process as much as possible to get 
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an accurate picture of the metabolic state.  Tissue biopsies are typically flash frozen in 
liquid nitrogen and stored at -80°C until future metabolite extraction.  
There are a few different extraction methods for RNA purification each with 
advantages and disadvantages.  The two most common methods are the acid guanidinium 
thiocyanate-phenol-chloroform (AGPC) and the silica column based method.  Although 
each method is acceptable for several experiments, the specific experimental 
requirements may suggest a specific method.  If speed and ease of use is desired, the 
silica column method is often employed whereas if higher purity is required the AGPC 
method is used.  For our experiment, the rapid silica based column, provided by Qiagen 
(Qiagen, Chatsworth, CA), provided satisfactory RNA quality and facilitated rapid 
analysis of our samples. 
Library Preparation 
 In order to sequence the extracted RNA it must be converted into molecules that 
can be sequenced by the specific sequencer.  For most technologies, including Illumina, a 
complementary DNA (cDNA) library is generated.  This method facilitates the adaptation 
of previously developed genomic tools to sequence DNA molecules and has been widely 
successful in transcriptomic studies
67
.  First mRNA is further purified by exploiting the 
poly-A tails using oligo-dT beads.  The Illumina platform requires shorter reads, so the 
purified mRNA is fragmented to suitable lengths.  These fragments are subsequently 
converted into cDNA by a reverse transcriptase.  In this manner, cDNA contains all 
expressed genes but omits non-coding DNA (ncDNA) sequences such as introns, 
enhancers, or other regulatory elements.  Adapters are subsequently bound and ligated to 
cDNA to allow sequencing. 
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Sequencing by Synthesis (SBS) 
 Sequencing by synthesis is the most common method for RNA-seq and is 
employed by Illumina.  In brief, the fragmented DNA is bound by oligonucleotide 
ligation adaptors.  These oligos facilitate hybridization to the surface of the ‘flow cell’, 
which is lined with the complementary oligos for the adapters.  The DNA molecules are 
amplified by bridge amplification.  A sequencing primer is subsequently bound to the 
opposite end of the molecules.  Sequencing proceeds with nucleotides that were 
developed to emit a specific color when excited by a laser which can be subsequently 
recorded to identify the bases.  This proceeds for a user-defined number of cycles 
resulting in large volumes of data which must be assembled and quantified. 
Data Analysis 
Mapping/Alignment 
 As previously mentioned, if the model organism has a previously sequenced 
genome the transcriptome can be mapped upon it.  This ‘reference-based’ (i.e. ab initio) 
mapping requires an alignment program to map cDNA reads to a genome.  There are 
several programs, commercial and open source, that are available to accomplish this 
analysis including BLAT
68
, TopHat
69
, SpliceMap
70
, MapSplice
71
, GSNAP
72
, and 
QPALMA
73
.  We selected TopHat for read mapping as it is a very fast mapper and one of 
the most commonly used open-source alignment programs
66
. 
Assembly 
 Once the reads have been mapped it becomes necessary to assemble them into 
transcription units.  This process is known as transcriptome assembly or reconstruction 
and is a difficult computational task.  Difficulties include the wide range of gene 
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expression levels (several orders of magnitude), genes originating from mature mRNA 
and incompletely spliced RNA complicate transcript identification, and short reads make 
it challenging to determine the correct isoform of a given read
74
.  When a reference 
genome is available, genome-guided methods are often used; however, de novo methods 
such as Velvet
75
 and ABySS
76
 are also available for non-model organisms.  Of the 
genome-guided methods we selected Cufflinks
77
, an assembly program developed by the 
same group which developed TopHat.  Cufflinks does not require extensive amounts of 
RAM and has improved detection of lower expressed transcripts than similar programs 
like Scripture
78
.  
Estimating Expression Levels 
 Quantifying expressing of transcripts is often the goal of transcriptomics 
experiments.  There are multiple levels of variation that impact the expression of reads 
including fragmentation (resulting in longer transcripts generating more reads) and 
fluctuations across samples.  As such, RNA-seq data requires normalization of read 
counts in order to interpret the data appropriately.  One common metric is the reads per 
kilobase of transcript per million mapped reads (RPKM) which normalizes a transcript’s 
count by the length and number of mapped reads in the samples
79
.  With respect to pair-
end sequencing, the similar fragments per kilobase of transcript per million mapped reads 
(FPKM) accounts for dependency between paired-end reads and is often the metric of 
choice
77
.  However, when comparing the same genes between samples the effect of gene 
length cancel out as the same gene will be affected the same way.  Furthermore, this 
standard scaling approach can bias estimates of differential expression in comparison to 
more general normalization procedures
80
 to account for different library sizes.  Raw 
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counts can be estimated with the HTSeq python script 
(http://www.huber.embl.de/users/anders/HTSeq/) and subsequently normalized.   
Differential Expression 
 Once reads have been quantified it is important to determine what is different 
between conditions.  The count-based data of RNA-seq can be modeled according to the 
Poisson distribution
81
.  However, biological variability is always a concern in high-
dimensional studies and this is not readily accounted for using the Poisson distribution.  
As a result, further methods have been developed that facilitate analysis of 
transcriptomics data sets with a small number of replicates.  These include Cuffdiff
77
 as 
well as R/Bioconductor packages DESeq
82
 and EdgeR
64
.  We have selected edgeR for 
differential expression because of the design matrix capability to incorporate repeated 
samples in addition to group comparisons (see Chapter 8). 
Bioinformatics Analysis 
 Once a list of interesting genes has been determined the goal shifts towards 
biological interpretation.  This is still a difficult and continuously developing area of 
bioinformatics.  Approaches can be divided into two general categories, functional and/or 
pathway analysis.  Functional analysis can be broadly defined as the study of overall 
functions.  This can include such broad categories as cellular processes to specific 
functions such as actin-myosin contraction.  Pathway analysis is sometimes used loosely 
when analyzing datasets; however, in keeping with the original idea pathway analysis is 
the study of up or down-regulated biological pathways such as glycolysis. 
In essence, most enrichment analysis methods utilize cumulated biological 
knowledge in a public database such as Gene Ontology
83
 or the Kyoto Encyclopedia of 
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Genes and Genomes (KEGG)
84
.  Dozens of methods, commercial and open-source, have 
been developed for both functional and pathway analysis including, but not limited to 
DAVID
85
, GSEA
86
, Ingenuity Pathway Analysis (Ingenuity Systems), and Onto-
Express
87
.  The details of each method exceed the scope of this thesis and the interested 
reading is referred to these comprehensive reviews
88,89
.    We have selected DAVID 
(Database for Annotation, Visualization and Integrated Discovery) because the analysis 
provides both functional annotations of each gene (Functional Annotation Table) and of 
each list of genes (Functional Annotation Clustering) to provide functional information.  
Additionally, the Functional Annotation Clustering tool consolidates redundancies in 
gene ontology categories.  In this way, DAVID provides a comprehensive exploratory 
analysis of our data (see Chapter 8).  
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CHAPTER 6 
 
Optimal Algorithm for Metabolomics Feature Selection and Classification varies by 
Dataset   
35 
 
ABSTRACT 
Metabolomics, the unbiased and systematic identification and quantification of all 
metabolites in a biological system, is increasingly applied towards identification of 
biomarkers for disease diagnosis, prognosis and risk prediction.  Applications of 
metabolomics extend across the health spectrum including Alzheimer’s, multiple forms 
of cancer, diabetes, and trauma.  Despite the continued interest in metabolomics there are 
numerous techniques for analyzing metabolomics datasets with the intent to classify 
group membership (i.e. Control or Treated).  These include Partial Least Squares 
Discriminant Analysis, Support Vector Machines, Random Forest, Regularized 
Generalized Linear Models, and Prediction Analysis for Microarrays.  Each classification 
algorithm is dependent upon different assumptions and can potentially lead to alternate 
conclusions.  This project seeks to conduct an in depth comparison of algorithm 
performance on both simulated and real datasets to determine which algorithms perform 
best with supporting theoretical justification.  Three simulated datasets were generated to 
validate algorithm performance and mimic ‘real’ metabolomics data: (1) independent null 
dataset (no correlation, no discriminatory variables), (2) correlated null (no 
discriminating variables), (3) correlated discriminatory.  This comparison is also applied 
to 3 open-access datasets including two NMR and one MS dataset.  Performance will be 
evaluated based on the Robustness-Performance-Trade-off (RPT) incorporating a balance 
between model accuracy and feature selection stability.  We also provide a free, open-
source R Bioconductor package (OmicsMarkeR) that conducts the analyses herein.  The 
proposed work provides an important advancement in metabolomics analysis and helps 
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alleviate the confusion of potentially paradoxical analyses thereby leading to improved 
exploration of disease states and identification of clinically important biomarkers.  
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INTRODUCTION 
Metabolomics, similar to the other two common ‘omics’ approaches (i.e. 
transcriptomics and proteomics), is defined as the unbiased and systematic identification 
and quantification of all metabolites in a biological system.  Such data is most commonly 
acquired via Nuclear Magnetic Resonance spectroscopy (NMR) or Mass Spectrometry 
(MS).  The growing field of metabolomics has been increasingly applied towards 
identification of biomarkers for disease diagnosis, prognosis and risk prediction.  
Applications of metabolomics extend across the health spectrum including Alzheimer’s90, 
multiple forms of cancer
91–93
, diabetes
94
, and trauma
95
.   
Following the initial pre-processing (e.g. peak picking, deconvolution, integration, 
etc.), the dataset must ultimately be analyzed to typically classify two or more 
classes/conditions in addition to identifying the most important metabolites for the 
discrimination (e.g. biomarker studies).  The availability and use of multivariate 
approaches is rapidly becoming critical with decreased cost and increased access to high-
throughput metabolomics platforms including NMR and MS resulting in “large p, small 
n” problems (i.e. many more variables than samples).  The common univariate tests 
become grossly underpowered to assess every feature and require a secondary model if 
classification is desired.  The restrictive assumptions of univariate tests (e.g. normality) 
are typically avoided with more sophisticated multivariate and machine learning 
algorithms.   
But despite the continued interest in metabolomics there is no standard statistical 
approach resulting in the use of numerous techniques that vary between experiments 
often with little or no justification.  Common methods include Partial Least Squares 
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Discriminant Analysis (PLSDA), Lasso and Elastic-Net Regularized Generalized Linear 
Models (GLMNET), Support Vector Machines (SVM), Random Forests (RF), Gradient 
Boosting Machines (GBM), and Prediction Analysis for Microarrays (PAM).  Although 
each method is an effective classification algorithm, previous comparisons of algorithms 
in gene expression experiments report that different algorithms provide improved 
accuracy
58
.  
 Limited algorithm comparisons in metabolomics studies (i.e. comparing two or three 
methods) often measure performance solely on accuracy and neglect feature selection 
stability.  Even though an analysis reports high accuracy, repeating the biomarker 
discovery procedures can result in different feature subsets even within the same 
datasets
96–98
.  Therefore, to determine which algorithms perform optimally must be 
evaluated with regards to both feature selection stability and overall classification 
accuracy.   
 In this work, we evaluate the 6 aforementioned classification algorithms 
performance and stability on both in silico and experimentally acquired datasets.  
Metabolomics datasets are inherently multivariate with both independent and 
multicollinear variables in addition to possessing a mix of Gaussian and non-Gaussian 
distributions.  To evaluate algorithm performance on such datasets it is necessary to 
generate standardized datasets that mimic true metabolomics data and possess known 
results as a benchmark.  Furthermore, an application to previously acquired datasets from 
multiple platforms with previous results is desired. 
METHODS 
Datasets 
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Although metabolomics has been more commonly used there is no standard 
dataset with known results for use in evaluating current or developing algorithms.  This 
necessitates the production of a simulated datasets that accurately mimic typical 
metabolomics datasets from both NMR and MS.  This requires the perturbation of 
normality in multiple variables and inclusion of multicollinearity as is typical of 
metabolite distributions and relationships.  It is also necessary to determine the 
performance of algorithms when examining the null condition wherein there is no 
difference between conditions.  Therefore, we propose to generate three simulated 
datasets (null independent, null correlated, and correlated discriminatory) to analyze 
algorithm performance that may also be used by others for further performance 
evaluations.  This will be repeated twice for matrices of both NMR and MS scale as the 
number of resolvable features between the two techniques can be an order of magnitude 
as NMR typically can resolve 50-75 metabolites whereas MS can resolve 100’s to 1000’s 
of metabolites
99
.  Although exceedingly large datasets are possible with in silico data we 
chose to select sample sizes that may more accurately reflect empirical datasets given the 
limits from costs and/or sample availability. Low and high sample sizes were set at 25 
and 50 samples per group respectively.  Although these are still high for many 
applications, this allows the use of leave k-fold out cross-validation.  For very small 
datasets one may use leave-one-out cross-validation or the option to forgo validation, if 
appropriate parameters are known, is available (optimize = FALSE). 
Simulated Datasets 
1. Null:  Simulated data will be generated with the create.random.matrix function as 
described in Wongravee et. al
100
 with the following noted modifications.  The initial 
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dataset will be generated with random numbers from a normal distribution, each 
consisting of N samples (nsamp, 25/50 per group) and Y variables (nvar, NMR = 50, 
MS = 1000).  The normal distribution will be perturbed and samples assigned to 
groups of equal numbers.  We chose to use an alternate numbers of samples and 
variables to represent more accurately numbers more commonly seen in the literature. 
2. Null Correlated:  To mimic ‘real’ metabolomics datasets, correlations will be induced 
for the second dataset with the create.corr.matrix function.  Blocks of variables of 
size b will be randomly assigned and have values replaced with correlated values 
derived from the first column.  We elected to incorporate blocks of size 1 as the 
smaller metabolomics datasets in NMR possess independent variables.  This induced 
correlation will be perturbed to more accurately represent real data.  Derived 
correlation coefficients will be compared to real metabolomics datasets to validate the 
method. 
3. Discriminatory:  To facilitate discriminatory analysis, D variables (NMR = 10, MS = 
20) will be randomly induced to be discriminatory with the create.discr.matrix 
function.  A discriminatory index (l) will be selected and for each variable D a 
random number between –l and l will be added to one group and subtracted from the 
other. 
Real Datasets 
NMR datasets include a binary (i.e. 2 groups) urine dataset analyzing cachexia
101
 
and multi-class (i.e. 4 groups) rumen fluid dataset investigating the impact of altered diets 
of cows
102
.  The MS explores potential biomarkers of Hepatocellular Carcinoma in serum 
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samples
103
 and was accessed from the open source metabolomics data repository 
Metabolights
104
 accession number MTBLS19. 
Classifier and Feature Selection Algorithms 
1. Partial Least Squares Discriminant Analysis (PLSDA) 
Partial Least Squares Discriminant Analysis is a dimension reduction technique 
analogous to principal component analysis.  The algorithm focuses on maximizing the 
variance of the dependent variables explained by the independent variables
105
.  It is 
robust to multicollinearity, missing data, and skewed distributions
106
.  Feature selection is 
accomplished by weighting the sum of squares of the variable weights known as variable 
importance of projection (VIP).  Feature selection is accomplished when features are 
ranked with respect to VIP scores to denote important variables.  Model derived features 
will be selected as those with a VIP score >= 1.0.  PLSDA is commonly used in 
metabolomics investigations including multiple forms of cancer, cardiac ischemia, 
parkinson’s disease and asthma43,93,107–111.  This technique has also been previously 
implemented in our lab investigating hemorrhagic shock
112
.  It is readily available in the 
R package DiscriMiner
113
. 
2. Regularized General Linear Model (GLMNET) 
Generalized linear models are a more flexible form of linear regression that allows 
the response variables to have non-parametric distributions.  To avoid the risk of 
overfitting data in multiple linear regression a regularization method can be applied.  We 
have selected to use the elastic-net penalty, which is a compromise between the LASSO 
and Ridge shrinkage methods and has been shown to outperform LASSO
114
.  In brief, 
elastic net is a weighted average of the lasso and ridge solutions determined the weighted 
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parameter lamda (λ).  This facilitates analysis of data with collinearity and facilitates 
internal feature selection.  Important features are identified as those with non-zero 
coefficients.  These coefficients will also be ranked for subset feature selection.  
Although it is less common than other techniques it has been used in recent metabolomics 
studies
115,116
.  GLMNET is readily available in the R package glmnet
117
. 
3. Random Forest (RF) 
Random forest is a machine learning algorithm that uses a combination of tree 
predictors such that each tree depends on the values of a random vector samples 
independently and the distributions are the same for all the trees in the forest.  Each tree 
constructed provides a ‘vote’ for the best class.  This is constructed on a training subset 
of the data and tested against the remaining test data known as the ‘out-of-bag’ (OOB) 
data.  The scaled sum of the votes derived from the trained trees determines the final 
“score”118.  The feature selection is determined by permuting variables in the OOB and 
observing increases in error.  These scores will be ranked for subset feature selection and 
those exceeding a score of 1.0 for model derived results.  A variable score indicates 
greater importance to the model.  It is robust to noise and outliers and computationally 
faster than bagging or boosting.  Prior studies have reported error rates comparable if not 
better than other predictors such as logistic regression, linear discriminant analysis, 
quadratic discriminant analysis (QDA), K-nearest neighbors (KNN), Support Vector 
Machines (SVM), classification and regression trees (CART) and Naïve Bayes
118–120
.  
However, consistency of selected feature rankings has been shown to be problematic
121
.  
It has been used in several metabolomics studies
122–125
 and is readily available in the R 
package randomForest
126
. 
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4. Gradient Boosting Machine (GBM) 
Gradient boosting is another machine learning technique applied most commonly to 
decision trees that produces robust and interpretable procedures for both regression and 
classification
127
.  Unlike the bagging approach (e.g. random forest) earlier trees are 
considered to compensate for prior weaknesses in subsequent trees.  As with random 
forest, feature selection is determined by permuting variables in the OOB and observing 
increases in error resulting in a subsequent variable score.  Feature selection will be 
accomplished via ranking scores and those exceeding 1.0 for model derived results.  
Boosting has become known as one of the most powerful learning ideas in the last twenty 
years
128
 but curiously has never been applied to metabolomics settings.  To our 
knowledge, this will be the first application of boosting to analyze metabolomics data.  
Freidman’s gradient boosting machine algorithm is available in the R package gbm129. 
5. Support Vector Machines (SVM) 
Support vector machine is based on the structural risk minimization principle from 
statistical learning theory
130
.  It can be applied to classification problems with the idea of 
structural risk minimization to find a hypothesis for which has the lowest probability of 
error.  It has been shown to be robust to both noisy data and outliers.  Prior comparisons 
with PLSDA report improved overall accuracy with less features
131
 but feature selection 
consistency is unknown.  This classification algorithm is readily available within the R 
e1071 package
132
.  Feature selection will be accomplished via recursive feature 
elimination (RFE) as detailed by Guyon
133
. 
6. Prediction Analysis for Microarrays (PAM) 
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Prediction Analysis for Microarrays is a modified nearest centroid classification 
method to include centroid shrinkage and contains an embedded feature selection step
134
.  
In brief, the average value for each variable is divided by the within-class standard 
deviation to provide class centroids.  These class centroids are then shrunk towards zero 
by a defined threshold to reduce noise and facilitate variable selection.  Then a new 
sample profile is compared to each of the class centroids.  The class whose centroid is 
closest is the predicted class.  The internal feature selection is accomplished by 
identifying features with non-zero coefficients and are subsequently ranked for subset 
selection.  This technique has not been used widely in metabolomics investigations; 
however, as the name implies it has been successfully been used for classification in gene 
expression experiments
135,136
.  This algorithm is readily available in the R package pamr. 
Evaluate Stability of Feature Selection Techniques 
The high-dimensional datasets of metabolomics often necessitate feature selection 
techniques to reduce dimensionality to the most important features to facilitate 
subsequent analysis.  Although many approaches rely exclusively on classification 
accuracy of feature subsets to facilitate biomarker selection this is problematic where 
several different feature subsets may yield equally optimal results
137
.  It is therefore 
necessary to evaluate the robustness of feature selection techniques applied to 
metabolomics data to facilitate improved reproducibility and confidence in identified 
biomarkers.  In brief, algorithm robustness will be evaluated via instance (bootstrapped 
data subsets) and function (alternate algorithms) perturbation and evaluated by the simple 
and commonly used Jaccard’s Index138.  Other options include the Dice-Sorensen’s 
Index
139,140, Ochiai’s Index141, Percent of Overlapping Features142, Kuncheva’s Index143, 
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Spearman Rank Correlation, and Canberra Distance
144
.  A comparison of these metrics is 
beyond the scope of this article. 
Two common approaches are applied within instance perturbation to evaluate the 
robustness of feature selection techqniues: perturbation at the instance level (i.e. 
removing or adding samples) or at the feature level (i.e. adding noise).  We have selected 
to evaluate robustness of feature selection algorithms by estimating stability following 
perturbation at the instance level as the number of samples are the most likely problem 
facing metabolomics investigations.   
Single Feature Selection Stability and Classification Performance 
For each feature selection algorithm we estimated stability via instance 
perturbation with the fs.stability function.  Instance perturbation parameters will bootstrap 
90% (p = 0.9) of the data 10 times (k = 10) thereby creating a training and testing dataset 
for each iteration.  For each training dataset all 6 feature selection algorithms were run 
simultaneously to provide a list of selected feature rankings.  Each iteration tunes the full 
model (optimize = TRUE) with a tuning grid of a specified resolution determining how 
fine the tuning parameters are optimized (resolution = 5). To avoid overfitting, 10-fold 
cross-validation is utilized (k.fold = 10) wherein 1/10
th
 of the data is randomly removed 
and the model evaluated on this test fold.  Results were averaged over all 10 folds to 
provide the confusion matrix for subsequent performance metrics.  The optimized models 
are then used to extract feature subsets of a user specified length (f, NMR = 10, MS = 20) 
or optionally by the model defined cutoff (model.features = FALSE).  These feature 
subsets are compared via the Jaccard index.  The overall stability is defined as the 
average over all pairwise similarity comparisons between each of the feature selection 
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runs.  The final model is refit using the extracted feature subset and re-optimized using 
the initial tuning grid generated.  Lastly, this trimmed model is used to predict the initial 
testing dataset generated at the start of the iteration.  The metrics include Accuracy and 
Area Under the Receiver Operator Curve (AUC-ROC).  These values were all extracted 
with the performance.metrics function to compare each algorithms performance.  This is 
repeated for the additional 9 times utilizing the previously optimized parameters for the 
full model generation (optimize.resample = FALSE). 
Balance Stability and Classification Performance 
In every scientific investigation in which sample size is a limitation (i.e. most 
studies), researchers must balance power and sensitivity.  The same principle is applied to 
balancing feature selection robustness and classifier performance as both are integral to 
confident biomarker identification.  We will utilize the robustness-performance trade-off 
(RPT) to balance robustness and classification performance
145
.  In brief, the user can 
specify the parameter β to control the relative importance of robustness versus 
classification.  The default value of β = 1 which represents equal importance between 
robustness and classification. 
Ensemble Feature Selection Stability and Classification Performance 
Ensemble feature selection has been shown to improve stability in gene 
expression studies
146,147
.  Therefore it is important to incorporate such analysis into 
metabolomics analysis for each algorithm.  In essence, ensemble approaches use different 
data subsets and aggregating the results following feature selection.  As described in the 
‘Single Feature Selection Stability and Classification Performance’ section, stability will 
be evaluated via instance perturbation with the fs.ensembl.stability function.  For each 
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subsample a second level of instance perturbation will generate 40 (bags = 40) further 
datasets via bootstrap aggregation (aka. Bagging)
148
.  For each bag a separate feature 
ranking will be performed.  The resulting list of selected feature rankings from each bag 
will be combined via linear aggregation (aggregation.metrics = “CLA”).  The Jaccard 
Index will be used to measure similarity and averaged over all pairwise comparisons for 
an overall measure of stability.  Function perturbation, the use of multiple feature 
selection algorithms, is also conducted by the list of methods chosen within fs.stability 
and fs.ensembl.stability.  Lastly, in contrast to non-ensemble approaches, there are no 
model derived runs because all features must be ranked for aggregation methods. 
RESULTS 
Simulated Data 
Binary Classification - Low Samples 
Non-ensemble analysis of random and correlated dataset analyses provided generally 
expected results.  Accuracy exceeded 0.700 for SVM, RF, GLMNET and PAM but 
stability remained low (>=0.47).  While RF achieved the highest accuracy (often in 
excess of 0.900), it had the lowest stability warranting caution in interpreting results.  
Notably, accuracy was generally higher with the MS-scale dataset where accuracy 
exceeded 0.900 for the same four algorithms.  However the stability of the feature subsets 
was also lower (Supplementary File – S1). 
Analysis of the NMR-scale discriminatory dataset determined PAM as the optimal 
model with the highest RPT and TP% of identified features (Table 1).  GLMNET 
performed similarly with better accuracy but lower stability and TP%.  The model 
derived analysis also provided PAM with the highest RPT, however, the low sample size 
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resulted in a conservative trimming of features resulting in many remaining in the model 
and decreasing the TP%.  The highest TP% was reported by SVM which also had the 
very high accuracy and AUC-ROC; however it is also noted that there is no internal 
trimming metric for SVM and only the top 10% of features are returned making this a 
more restricted subset model.  This suggests that experiments with lower sample sizes 
may need to restrict to only a few of the most discriminate features.  The MS-scale 
datasets determined also reported PAM with the highest RPT and stability but the highest 
TP% was reported by PLSDA.  Such a situation supports the value of using multiple 
algorithms to determine consistent results. 
Ensemble analysis of NMR-scale and MS-scale random and correlated datasets again 
reflected previous analysis with high accuracy levels for SVM, RF, GLMNET and PAM 
but low stability (Appendix B – Tables 2 & 6).  Analysis of NMR-scale discriminatory 
dataset reported SVM with the highest RPT with PLSDA, GLMNET and PAM 
performing similarly.  The MS-scale analysis was less conclusive with mixed 
performance among SVM, GLMNET and PAM (Appendix B – Table 10). 
Binary Classification – High Samples 
Increased sample size had little effect on accuracy and stability of NMR-scale random 
and correlated datasets but worsened models of MS-scale data (Appendix B – Table 5).  
Overall performance greatly improved in the NMR-scale discriminatory dataset with 
accuracy exceeding 0.9 for three algorithms, stability exceeding 0.8, and TP% to 80% 
(Table 1).  Performance in the MS-scale dataset also improved with stability and TP% 
increasing most notably for GBM and RF respectively (Appendix B – Table 9).  Both 
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datasets provide a circumstance whereby no algorithm performs best and multiple 
methods are beneficial. 
As expected, there was little effect of high samples on the ensemble analysis of the 
both random and correlated datasets of MS-scale and NMR-scale sizes.  The results of 
the ensemble NMR-scale discriminatory dataset improved RF and SVM but worsened 
GLMNET and PAM (Table 1).   Likewise, the ensemble MS-scale discriminatory dataset 
also improved performance (Appendix B – Tables 9).  However, the best performing 
algorithms were PLSDA, PAM and GLMNET.  These results suggest that ensemble 
aggregation may improve, worsen, or have no effect on model performance. 
Multiclass Classification - Low-Samples 
NMR-scale random and correlated datasets generally had low accuracy and stability 
whereas MS-scale had four algorithms consistently had accuracy >= 0.700 but stability 
still remained low (Appendix B – Table 8).  Analysis of the NMR-scale discriminatory 
dataset determined SVM as the best performing algorithm with the highest RPT whereas 
PAM and RF had the highest stability and accuracy respectively.  The model derived 
results report GLMNET and PAM among the best; however, as with the binary 
classification problems the low sample size resulted in untrimmed features wherein 
nearly all were retained resulting in a decreased TP%.  Curiously, SVM reported the 
highest TP% (64%) again suggesting that the lower sample size may restrict to only a few 
of the most discriminating features (Table 2).  The MS-scale dataset had high predictive 
accuracy with SVM, GLMNET and PAM but very low with PLSDA and GBM.  
Curiously, PLSDA had the highest TP% but in addition to a fair AUC-ROC (0.721) and 
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stability (0.53) suggesting a potential use in comparison to better classifying algorithms 
for feature selection (Appendix B – Table 12). 
Ensemble analysis of random and correlated datasets had little effect on performance 
of both NMR-scale and MS-scale (Appendix B – Table 8).  Analysis of the NMR-scale 
discriminatory dataset reported GLMNET with the highest RPT but PLSDA with the 
highest TP% (Table 2).  This reflects the single run analysis whereby the improved 
stability of ensemble methods provided improved classification and stability of 
GLMNET.  The MS-scale analysis reported SVM as the optimum algorithm with the 
highest RPT and accuracy but PAM reported the highest TP% (Appendix B – Table 12). 
Multiclass Classification - High Samples 
NMR-scale random and correlated datasets continued to provide expected results, 
whereby most models had poor classification.  In contrast, MS-scale data provided high 
accuracy but continued to provide very poor stability (Appendix B – Table 7).  Analysis 
of the NMR-scale discriminatory dataset determined GLMNET as the best performing 
algorithm despite lower accuracy (Table 2).  Model derived results determined GLMNET 
and PAM as the best models however they did not successfully extract any discriminating 
features resulting in a depleted TP% whereas SVM reported the highest TP% at 60%. 
Ensemble analysis of random and correlated datasets again reflected previous analysis 
with low accuracy and stability for both NMR-scale and MS-scale data.  Analysis of the 
discriminatory dataset did not significantly improve performance for the NMR-scale 
dataset.  This is also reflected in the MS-scale data where only RF and PLSDA stability 
improved slightly (Appendix B – Table 11). 
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  Method RPT Accuracy AUC-ROC Stability # Features TP % 
Binary 
High 
Sample 
Subset 
PLSDA 0.923 0.982 0.551 0.87 10 80.0% 
GBM 0.748 0.710 0.730 0.79 10 76.0% 
SVM 0.742 1.000 1.000 0.59 10 61.0% 
RF 0.529 1.000 1.000 0.36 10 59.0% 
GLMNET 0.942 1.000 1.000 0.89 10 80.0% 
PAM 0.936 1.000 1.000 0.88 10 80.0% 
Model 
Derived 
PLSDA 0.931 0.965 0.698 0.90 10 80.0% 
GBM 0.552 0.480 0.705 0.65 14 55.0% 
SVM 0.770 0.990 1.000 0.63 5* 68.0% 
RF 0.549 0.990 1.000 0.38 17 38.8% 
GLMNET 0.927 0.980 0.984 0.88 8 92.5% 
PAM 0.860 0.990 0.985 0.76 44 22.5% 
Ensemble 
PLSDA 0.928 0.982 0.551 0.88 10 80.0% 
GBM 0.562 0.430 0.773 0.81 10 80.0% 
SVM 0.773 1.000 1.000 0.63 10 76.0% 
RF 0.765 1.000 1.000 0.62 10 76.0% 
GLMNET 0.817 1.000 1.000 0.69 10 66.0% 
PAM 0.930 1.000 1.000 0.87 10 80.0% 
Low 
Sample 
Subset 
PLSDA 0.690 0.875 0.705 0.57 10 61.0% 
GBM 0.395 0.300 0.669 0.58 10 56.0% 
SVM 0.667 1.000 1.000 0.50 10 48.0% 
RF 0.359 0.975 1.000 0.22 10 48.0% 
GLMNET 0.801 0.975 1.000 0.68 10 68.0% 
PAM 0.806 0.900 0.831 0.73 10 78.0% 
Model 
Derived 
PLSDA 0.792 0.895 0.597 0.71 14 50.0% 
GBM 0.585 0.525 0.744 0.66 20 36.5% 
SVM 0.802 1.000 1.000 0.67 5* 68.0% 
RF 0.406 0.925 1.000 0.26 17 25.9% 
GLMNET 0.830 1.000 1.000 0.71 32 28.4% 
PAM 0.925 1.000 1.000 0.86 48 20.8% 
Ensemble 
PLSDA 0.694 0.863 0.856 0.58 10 66.0% 
GBM 0.455 0.350 0.750 0.65 10 62.0% 
SVM 0.788 1.000 1.000 0.65 10 70.0% 
RF 0.606 0.975 1.000 0.44 10 56.0% 
GLMNET 0.765 0.975 1.000 0.63 10 57.0% 
PAM 0.748 0.900 0.831 0.64 10 72.0% 
Table 1 – Results from NMR-scale Binary Classification Simulations.  RPT – Robustness-Performance 
Trade-off, AUC-ROC – Area under the Receiver Operator Curve, TP % - Percent true positive 
identifications. *SVM doesn’t have internal cutoff so defaults to top 10% 
  
53 
 
 
 
Method RPT Accuracy AUC-ROC Stability # Features TP % 
Multi-
class 
High 
Sample 
Subset 
PLSDA 0.432 0.380 0.622 0.50 10 49.0% 
GBM 0.398 0.340 0.691 0.48 10 46.0% 
SVM 0.531 0.565 0.846 0.50 10 42.0% 
RF 0.257 0.900 0.966 0.15 10 30.0% 
GLMNET 0.615 0.575 0.837 0.66 10 52.0% 
PAM 0.586 0.520 0.670 0.67 10 53.0% 
Model 
Derived 
PLSDA 0.441 0.373 0.678 0.54 12 44.2% 
GBM 0.926 0.895 0.823 0.96 50 19.6% 
SVM 0.559 0.485 0.803 0.66 5 60.0% 
RF 0.326 0.875 0.940 0.20 19 16.3% 
GLMNET 0.786 0.675 0.986 0.94 50 20.0% 
PAM 0.780 0.640 0.730 1.00 50 20.0% 
Ensemble 
PLSDA 0.456 0.380 0.623 0.57 10 54.0% 
GBM 0.344 0.265 0.757 0.49 10 44.0% 
SVM 0.467 0.510 0.820 0.43 10 39.0% 
RF 0.299 0.890 0.950 0.18 10 35.0% 
GLMNET 0.538 0.495 0.806 0.59 10 34.0% 
PAM 0.557 0.520 0.670 0.60 10 52.0% 
Low 
Sample 
Subset 
PLSDA 0.485 0.394 0.815 0.63 10 58.0% 
GBM 0.397 0.325 0.666 0.51 10 38.0% 
SVM 0.723 0.888 0.904 0.61 10 52.0% 
RF 0.356 0.938 0.967 0.22 10 39.0% 
GLMNET 0.673 0.688 0.875 0.66 10 52.0% 
PAM 0.715 0.675 0.761 0.76 10 53.0% 
Model 
Derived 
PLSDA 0.501 0.425 0.661 0.61 13 40.8% 
GBM 0.517 0.375 0.739 0.83 47 20.4% 
SVM 0.752 0.800 0.888 0.71 5 64.0% 
RF 0.365 0.888 0.954 0.23 17 21.2% 
GLMNET 0.871 0.863 0.938 0.88 49 19.4% 
PAM 0.900 0.825 0.838 0.99 50 20.0% 
Ensemble 
PLSDA 0.485 0.394 0.815 0.63 10 62.0% 
GBM 0.388 0.300 0.665 0.55 10 38.0% 
SVM 0.654 0.788 0.917 0.56 10 53.0% 
RF 0.389 0.875 0.996 0.25 10 39.0% 
GLMNET 0.751 0.763 0.913 0.74 10 47.0% 
PAM 0.746 0.775 0.802 0.72 10 53.0% 
Table 2 – Results from NMR-scale Multi-class Classification Simulations.  RPT – Robustness-Performance 
Trade-off, AUC-ROC – Area under the Receiver Operator Curve, TP % - Percent true positive 
identifications.  *SVM doesn’t have internal cutoff so defaults to top 10% 
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REAL DATASETS 
Eisner – Urine analysis of Cachexia via NMR  
Non-ensemble analysis determined PAM and GLMNET as the best overall 
models according the RPT (0.711, 0.705).  Important features were extracted with the 
feature.table function.  Adipate, Glucose, 3-Hydroxyisovalerate were identified in all 
subsamples by both models.  PAM also identified creatine and succinate consistently 
(Table 3).  GLMNET identified leucine, quinolinate, and valine as important features 
(Table 4).  Seven of these metabolites were within the top 10 metabolites identified by 
Eisner et. al.
101
 with creatine being the 11
th
.  Furthermore, the other 3 metabolites in the 
top 10 (myo-inositol, betaine, and N,N-dimethylglycine) were also identified in the top 10 
by GLMNET and PAM.  Random forest provided the best classification accuracy at the 
expense of stability.  SVM performed similarly well with respect to classification 
accuracy (Appendix B – Table 13), however, stability was also quite low (0.31). 
Ensemble methods improved stability of GBM, SVM, and RF; however, it 
noticeably decreased GLMNET stability from 0.64 to 0.49 (Appendix B – Table 16).  
Performance decreased slightly for PLSDA but improved for PAM; both proved the best 
overall models.  Overall 8 of the 9 identified metabolites (frequency >= 0.9) by PLSDA 
and PAM were in the top 10 identified by Eisner et.al. (Appendix B – Tables 17 & 18).  
For this particular dataset the ensemble approach does not appear necessary as neither 
model performance nor feature stability was significantly improved.  Irrespective, the 
applied methods provide further validation and support for the classification and 
metabolites selected. 
  
55 
 
PAM Feature Table 
features consistency frequency 
Adipate 10 1 
Creatine 10 1 
Glucose 10 1 
Succinate 10 1 
X3.Hydroxyisovalerate 10 1 
myo.Inositol 9 0.9 
Betaine 7 0.7 
Glutamine 7 0.7 
Quinolinate 6 0.6 
cis.Aconitate 6 0.6 
Acetate 5 0.5 
N.N.Dimethylglycine 5 0.5 
Lysine 3 0.3 
Leucine 2 0.2 
Table 3 – Feature table of PAM analysis consisting of consistency (i.e. number of times the 
feature identified as important) and frequency (i.e. percentage of iterations feature identified). 
 
GLMNET Feature Table 
features consistency frequency 
Adipate 10 1 
Glucose 10 1 
Leucine 10 1 
Quinolinate 10 1 
Valine 10 1 
X3.Hydroxyisovalerate 10 1 
myo.Inositol 9 0.9 
Succinate 6 0.6 
Betaine 4 0.4 
Glutamine 4 0.4 
Lysine 4 0.4 
Creatine 3 0.3 
N.N.Dimethylglycine 3 0.3 
Acetate 3 0.3 
Alanine 2 0.2 
Formate 1 0.1 
Xylose 1 0.1 
Table 4 – Feature table of GLMNET analysis consisting of consistency (i.e. number of times the 
feature identified as important) and frequency (i.e. percentage of iterations feature identified). 
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Ametaj – Analysis of Rumen Metabolism via NMR 
The PAM and GLMNET models performed very well with the Ametaj dataset 
with RPT values of 0.850 and 0.806 respectively.  Although PLSDA did not have a high 
RPT (0.497), the stability was very high (0.77) and was therefore evaluated for 
consistency with PAM and GLMNET.  Glucose, endotoxin, and methylamine were 
consistently identified by PAM, GLMNET and PLSDA (Appendix B – Tables 20-22).  
Glucose and endotoxin were expected and methylamine was the first statistically 
significant metabolite discussed by Ametaj et.al.
102
.  In addition, uracil, acetate, fumarate, 
and lactate were also consistently identified by at least two models.  All of these 
metabolites are identified by Ametaj et.al. except for lactate which is reported as non-
significant but was approaching significance (0.149).  This suggests a potential power 
issue although the authors’ comment on the conversion of lactate to proprionate in 
ruminates is well supported. 
Ensemble methods improved stability of PLSDA, GBM, SVM, and RF; however, 
it slightly decreased GLMNET and PAM stability by 0.02 and 0.07 respectively 
(Appendix B – Table 23).  This general improvement is expected with smaller sample 
sizes as variability often greater.  The stability of all models was very high with all ≥ 0.67 
except for RF.  Stability of PLSDA was highest; however, classification accuracy was 
poor (0.438).  Accuracy increased slightly with PAM and GLMNET but decreased in 
SVM to match GLMNET.  These three proved to be the best overall models.  Although 
the stability was high, identified features did vary between models creating what we refer 
to as a ‘hierarchy of confidence’ whereby the greatest confidence would be placed in the 
most consistently identified features within and across algorithms.  Endotoxin, glucose, 
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and methylamine were once more identified by four models (PAM, SVM, PLSDA and 
GBM).  Alanine was also identified by 3 models (PAM, GLMNET, PLSDA).  In 
addition, acetate, 3-PP, and uracil were also identified by at least two models 
consistently.  All of these metabolites were identified as important by Ametaj et.al.  
Lastly, although most results were consistent, ferulate was also identified by PAM and 
SVM which was not discussed previously.  It is also apparent that given the small sample 
size and greater variability within the data, this analysis benefits from ensemble methods.   
Xiao – Serum Analysis of Hepatocellular Carcinoma via MS   
Within the negative mode comparisons PAM mostly performed better than all 
other algorithms applied with respect to RPT (Appendix B – Tables 28-35).  There was 
only one exception where PAM and GLMNET had almost identical RPT values (0.679, 
0.680).  However, PAM stability was consistently the highest suggesting it to be the ideal 
method to explore this particular dataset.  Additionally, it should be noted that PAM did 
not have very high accuracy compared to other methods such as GLMNET and SVM.  
Random Forest also had very high accuracy but exceptionally low stability making it a 
good tool for analyses that require high classification accuracy but do not require further 
feature identification.  The higher accuracy makes GLMNET a close second to the PAM 
approach.  An ensemble analysis was performed, however only RF improved stability 
significantly rendering the ensemble analysis of little help.  Identified features were 
largely consistent with previous analyses (Supplementary File 7), however, each 
comparison identified at least an additional 15 metabolites not mentioned in the published 
manuscript. 
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Within the positive mode comparisons GLMNET performed slightly better than 
PAM in all except the 1 comparison; however, PAM consistently maintained the highest 
stability demonstrating that even with very high-dimensional datasets no single algorithm 
dominates.  As with the negative mode, an ensemble analysis was performed but only RF 
improved stability significantly making ensemble aggregation unnecessary.  As with the 
NMR studies the two models provided further support to mutually identified features 
(Supplementary File  8).  These features included GDCA, Oleoylcarnitine, GCDCA, L-
N2-(2-Carboxyethyl) arginine, Tetracosahexaenoic acid, Palmitoyl carnintine and 
Linoelaidyl carnitine which support the author’s interpretations of bile and fatty acid 
metabolism.  In addition, 48 metabolites were consistently identified by PAM but were 
not mentioned in the paper however it is possible they were identified as the authors do 
not present all identified metabolites. 
DISCUSSION 
The results presented focus on determining if a single classification algorithm 
performs better than other commonly used algorithms in the field of metabolomics.  
Although there is strong support for several algorithms, there are additional papers stating 
one algorithm outperforms another.  This is expected according to the concept of No Free 
Lunch Theorem
149
 which in essence states that there is no single model that is appropriate 
for all problems.  Our analyses support this theory and suggest a comparative approach to 
evaluate algorithm performance as well as to provide additional support via multiple 
algorithms for future conclusions.  As such, the Bioconductor package OmicsMarkeR 
was created to facilitate the rapid comparison of algorithm performances on individual 
datasets. 
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The binary and multivariate simulation results demonstrate the variation in 
optimal models.  Depending on the users approach to a dataset (i.e. feature subset or 
model derived), number of samples relative to features, the number of groups, or 
application of ensemble methods a different algorithm may be more appropriate.  Within 
the simulation analyses PLSDA, SVM, PAM, RF, and GLMNET all proved to be optimal 
algorithms for different situations.  Curiously, the reduction in features generally 
decreased GBM performance but feature selection was relatively consistent with other 
methods.  Random Forest, in most cases, did not prove to be the optimal algorithm but 
consistently had among the highest accuracy but very low stability; which could be 
partially mitigated by an ensemble approach.  This low stability is expected given the 
algorithms search encompasses interactions between variables resulting in a larger search 
space.  If a user wished to weigh accuracy more than stability, the RPT value can be 
easily recalculated with the RPT function by increasing the beta parameter (e.g. beta = 
1.5 increases the weight of accuracy by 50%). 
The Eisner cachexia NMR dataset provided an example of the value behind using 
multiple algorithms.  In the event that algorithms have similar overall performance, 
analysis of features selected by both may provide further support for identified features.  
Additionally, this dataset demonstrated the circumstance whereby ensemble approaches 
are superfluous.  Consistent with published results, the Eisner dataset did reflect the high 
accuracy of SVM but stability was low.  The GLMNET and PAM analyses provided 
respectable accuracy and high stability.  The ability to assess stability of identified 
features for classification models is valuable if rapid and clinically applicable tests are to 
be developed. 
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The Ametaj cow diet NMR dataset also benefited from multiple algorithms 
adding further support to identified features.  Furthermore, the multi-class experimental 
design and low number of samples likely resulted in higher variability.  As such the 
ensemble approach was beneficial by improving most algorithm performances. 
The Xiao Hepatocellular Carcinoma MS dataset was analyzed in four separate 
comparisons within each mode (i.e. positive or negative) following the manuscripts 
analysis.  The negative mode results suggest that PAM is generally the optimum 
algorithm with respect to RPT values.  The positive mode results suggest that GLMNET 
is the optimum algorithm.  However, the goal behind the study was the identification of 
biomarkers.  As such, the consistently higher stability of PAM is noteworthy.  A potential 
extension would be to use the features identified by PAM and build the GLMENT model 
(or other method) for class prediction to improve accuracy and/or AUC-ROC. 
As an example, we provide a very concise sample summary of the final positive 
comparison which could be used as a general guideline for reporting results: Six 
commonly applied metabolomics algorithms were tuned and cross-validated with the 
OmicsMarkeR bioconductor package via 10-fold cross-validation (k.fold = 10).  Feature 
selection was accomplished with default model parameters.  After comparison of overall 
performance Prediction Analysis of Microarrays (PAM) provided the highest 
Robustness-Performance-Trade-off (RPT) balancing both classification accuracy (73%) 
and stability of identified metabolites (Jaccard = 0.74) reflecting good prediction and 
reproducible metabolite identification.  Metabolites identified in all data perturbation 
runs (k = 10) include GDCA, Oleoylcarnitine, GCDCA, L-N2-(2-Carboxyethyl) arginine, 
Tetracosahexaenoic acid, Palmitoyl carnintine and Linoelaidyl carnitine.  Forty-eight 
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(48) additional metabolites were consistently identified that may be pursued via tandom 
mass spectrometry (MS/MS). 
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Figure 1.  General guideline for which algorithms to apply to a given dataset.  The reader is still 
encouraged to compare multiple algorithms and employ ensemble analysis given the variability in 
biological datasets. 
 
CONCLUSION 
Within this paper, we used simulated datasets to demonstrate that algorithm 
performance varies depending on the investigator’s approach to a dataset (i.e. defined 
number or unknown), number of samples relative to features, the number of groups, 
and/or if ensemble methods are applied.  We also applied this comparative approach to 
three published, typically designed and freely accessible datasets including two NMR and 
one MS datasets.  Following tuning and cross-validation, the optimal algorithms were 
used to compare selected features to the respective studies.  Results proved very 
consistent identifying the most discriminating features; however, additional features were 
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also identified that demonstrate the variation in applied methods and complexity of these 
large datasets.  
 This comparative analysis provides a means to objectively choose a particular 
algorithm in addition to stability metrics to provide the highest confidence in potentially 
identified biomarkers and direct more focused independent validation.  From these results 
the choice of the ‘best’ algorithm appears dependent upon the goals of the experiment in 
addition to the structure of the dataset. If classification is the primary goal, Random 
Forest is an excellent option.  If feature selection is also important there a few options the 
must be considered such as the number of expected discriminatory features and the 
datasets scale (i.e. MS or NMR).  The diagram in Figure 1 is meant to be a general guide; 
however, the results herein strongly suggest using multiple algorithms and comparing 
performance on each unique dataset as well as ensemble methods which have been made 
far more accessible with the OmicsMarkeR package. 
 In addition, the package contains two permutation functions (perm.class and 
perm.features) for assessing model performance and identified features for further 
evaluation.  Current areas of improvement include the addition of further algorithms, 
improving memory efficiency and easy to access graphics (e.g. scores plots, variable 
importance plots, etc.).  The R package OmicsMarkeR for this analysis is publically 
accessible from the bioconductor platform (www.bioconductor.org).  
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CHAPTER 7 
 
Fed State Alters the Metabolomic Response to Hemorrhagic Shock and Resuscitation  
in Porcine Liver   
65 
 
ABSTRACT 
Hemorrhagic shock with injury results in alterations of the metabolic state of an 
organism, which contribute to organ dysfunction and death.  Previous investigations have 
explored the effects of carbohydrate prefeed in murine models but few in clinically 
relevant large animal models.  We performed carbohydrate prefeed in pigs undergoing 
simulated polytrauma and hemorrhagic shock with resuscitation to determine if 
carbohydrate prefeeding if the metabolic response to shock is dependent on fed state.  
Sixty four (64) Yorkshire pigs were divided into two experimental groups: fasted (32) 
and pre-fed (32).  Experimental animals were subjected to a standardized hemorrhagic 
shock protocol, including pulmonary contusion and liver crush injury. To determine 
molecular alterations in response to trauma as a result of pre-feeding, liver biopsies were 
obtained at set timepoints throughout the procedure.  Fifty-one (51) metabolites were 
profiled for each sample via proton nuclear magnetic resonance spectroscopy (
1
H-NMR).  
Partial-Least Squared Discriminant Analysis (PLS-DA) was used to examine clustering 
of the data with respect to fed state.  Cross-validated models separated the fed from fasted 
animals.  Metabolites contributing to the separation have known relationships to alternate 
carbon energy sources, amino acid metabolism, oxidative stress response, and membrane 
maintenance.  In conclusion, we validated an alternate response to shock and 
resuscitation, dependent upon fed state, through the use of metabolomics.  
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INTRODUCTION 
Hemorrhagic shock is a leading cause of trauma-related mortality in both civilian 
and military settings.  Efforts over the years have significantly improved survival in the 
military sector
150
;  however, hemorrhagic shock remains the most common cause of 
preventable injury in both the civilian and military sectors
151–154
.  Hemorrhagic shock 
from traumatic injury results in multiple alterations in the metabolic state of an organism 
many of which are not fully elucidated.   
Hemorrhagic shock results in inadequate tissue perfusion leading to decreased 
oxygen availability to mitochondria resulting in a switch towards anaerobic.  The liver 
serves an important function as a regulator of metabolism during stressed states.  Initially, 
the shift towards anaerobic metabolism stimulates the liver to increase glycogenolysis 
and process elevated lactate produced in the peripheral tissues.  The liver also provides a 
major site of detoxification and production of alternate metabolic fuel sources including 
amino acids and lipids.  Effects of different fed states on liver metabolic processes 
following injury and hemorrhagic shock are not well known.   
Metabolomics, a high-throughput profiling of all the metabolites within a 
sample
12
, has the ability to identify multiple metabolites simultaneously.  This ability 
potentially permits the elucidation of altered cellular and metabolic pathways in addition 
to potentially furthering our understanding of the metabolic response to hemorrhagic 
shock with respect to metabolic state.  Practical applications of metabolomics include 
classification and diagnosis of several forms of cancer and neurodegenerative disorders
14
.  
In addition, our laboratory has successfully applied metabolomics tools to a clinically 
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relevant porcine model of hemorrhagic shock in order to identify biomedical pathways 
and to associate metabolic changes with phase of care
42,46,112
. 
Of interest herein is the impact of fed state upon the response and recovery from 
hemorrhagic shock and injury.  Prior work from our group reported a significant increase 
in lung injury in animals receiving a carbohydrate prefeeding immediately prior to injury 
compared to fasted animals (44% vs. 15%, p = 0.03)
155
.  This difference in outcome 
between fed and fasted animals led us to ask the question regarding possible drivers of 
difference in response.  One of the potential mechanisms possible is a difference in 
metabolism driven by carbohydrate prefeeding.  The objective of this study was to 
determine if the liver responds differently in our clinically relevant model of polytrauma 
and hemorrhagic shock with respect to fed state with the hypothesis that there would be 
quantifiable differences in liver metabolites reflecting an altered metabolic response to 
shock and resuscitation depending upon fed state.  The liver is an important regulator 
during stress and serves as a primary site of gluconeogenesis to meet peripheral glucose 
requirements thereby making it an ideal location to evaluate alterations in metabolic 
response.  To test this hypothesis, we used our well-established model of hemorrhagic 
shock and polytrauma comparing the effect of providing a carbohydrate prefeed (CPF) 
versus a fasted (FS) diet prior to insult.  Proton (
1
H) NMR spectroscopy was used to 
determine concentrations of metabolites in liver biopsies taken at defined timepoints 
throughout shock and resuscitation with the goal to identify altered metabolic responses 
in prefed versus fasted animals so that we may understand potential contributing factors 
of metabolic state to outcome. 
METHODS 
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Animals 
Male Yorkshire-Landrace pigs (15-20 kg) were purchased from Manthei Hog Farm, LLC 
(Elk River, MN) and housed in Research Animal Resources (RAR) at the University of 
Minnesota.  All studies were approved by the Institutional Animal Care and Use 
Committee.  Pigs were fasted overnight prior to surgery, but were allowed water ad 
libitum. 
Animal Preparation and Hemorrhagic Shock Protocol 
Sixty four (64) juvenile, male Yorkshire pigs were used in this study.  Results from this 
group of animals have been previously published
42,46,155
.  All animals were fasted 
overnight.  Two experimental groups were utilized: Carbohydrate Prefed (CPF, n = 32) 
and Fasted (FS, n = 32).  CPF animals were given 7cc/kg bolus of Karo Syrup
®
 (mixture 
of sugars including ~ 15% glucose, maltose, fructose and sucrose) diluted with water 1 
hour prior to induction of anesthesia.  The full experimental polytrauma and shock 
protocols have been described in detail previously
46,112
 and in Chapter 2.  Briefly, animals 
were instrumented and splenectomized.  Polytrauma was induced by a captive bolt device 
to create a blunt percussive injury to the chest and a liver crush injury using a Holcomb 
clamp technique
20
.  Hemorrhagic shock was then induced by withdrawal of blood from 
the inferior vena cava until a systolic pressure of 45 to 55mmHg was reached for 45 
minutes (S45) to simulate delay prior to medical attention.  Typically, this resulted in 
withdrawal of approximately 40% of the pig’s blood volume.  Blood was placed in an 
acid-citrate-dextrose bag for later use.  Following the shock period, animals received 
lactated Ringer’s fluid given as 20 cc/kg intravenous (IV) boluses to maintain a systolic 
blood pressure greater than 80 mmHg for one hour of limited resuscitation to simulate 
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transportation to a medical center; then underwent full resuscitation protocol for the 
following 24 hours (Appendix A).  This resuscitation included fluid, shed blood, and 
ventilator support in a protocolled fashion.  After the resuscitation period, animals were 
extubated and sent to recovery and subsequently euthanized. 
 At several time points throughout the experiment, liver biopsies were taken from 
the periphery of the liver ranging in weight from 0.2 to 0.6 grams.  Biopsies were flash 
frozen in liquid nitrogen and stored at -80°C until preparation for NMR analysis.  
Biopsies were taken at the following timepoints: baseline after the animal stabilized from 
instrumentation (B), 45 minutes after hemorrhage (S45), 2, 8, and 20 hours after full 
resuscitation (FR2, FR8, FR20).  Changes induced by hemorrhagic shock polytrauma and 
‘early’ resuscitation were denoted as the difference between S45 and B (S45-B) and 
between FR2 and S45 (FR2-S45) respectively.  
Liver Metabolite Extraction 
 Stored liver samples were prepared for NMR analysis using a variation of the 
perchloric acid (PCA) extraction technique
156
.  Frozen liver samples were weighed and 
pulverized into a fine powder using a mortar and pestle in liquid nitrogen, weighed, and 
kept on ice in eppendorf tubes.  Perchloric acid (6%) was added at 5mL/g of tissue and 
vortexed for 30 seconds.  Samples were incubated for 10 minutes and subsequently 
centrifuged at 12,000g for 10 min at 4°C.  The supernatant was collected, pH neutralized 
with 2M K2CO3 to 7.4, incubated on ice for 30 min and centrifuged once more at 12,000g 
for 10 min at 4°C.  The supernatant was collected, frozen and lyophilized in a 
LABCONCO Freezone 6 Plus freeze-drier (Kansas City, MO). 
NMR Spectroscopy 
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 Lyophilized samples were rehydrated with 500µl D2O and 50µl of internal 
standard 3mM DSS (Dimethyl-Silapentane-Sulfonate, Sigma-Aldrich, St. Louis, MO).  
Solution pH was adjusted with DCl and NaOD to 7.4.  The final volume was brought to 
600µl using D2O and the sample was transferred into a 5mm tube (Wilmad, Vineland, 
NJ) 
 
1
H NMR spectra were obtained using a Varian 600 MHz spectrometer with a 
5mm HCN triple resonance probe.  Spectra were generated from 128 scans with a basic 
1
H acquisition protocol consisting of a 45° tip angle, a relaxation delay of 1 sec and an 
acquisition time of 1.9 sec.  All NMR spectra were phase and baseline-corrected and 
chemical shifts were referenced to the DSS internal standard. 
 Chenomx software
56
 was used to identify and quantify metabolites present in each 
liver sample.  Fine manual phasing and baseline corrections were applied to each 
spectrum before targeted profiling was performed.  Fifty-one (51) metabolites were fit in 
each liver sample in this study, resulting in a profile containing the concentration of each 
identified metabolite in millimoles per liter (mM), as determined by comparison to the 
internal standard.   
Statistical Analysis 
 A multivariate approach was used to analyze each of the timepoints.  To 
determine the response to shock and resuscitation, changes in concentration between 
baseline and subsequent timepoints were analyzed.  All statistical analysis was conducted 
using the open source R statistical program
157
.  For each timepoint/difference the fifty-
one profiled metabolites were auto-scaled and mean-centered prior to initial Principal 
Component Analysis (PCA).  Samples that fell outside a 95% Hotelling’s ellipse were 
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considered outliers and removed from further analysis.  Datasets, with outliers removed, 
were subsequently analyzed by Partial Least Squares Discriminant Analysis (PLS-DA), a 
common discrimination technique utilized in metabolomics
158–160
 that has been 
successfully employed in our previous studies
42,112
.  The R packages DiscriMiner
113
 and 
Permute
161
 were used collectively to conduct the PLS-DA model, cross-validation, and 
permutation tests.  PLS-DA models were optimized based on the number of 
misclassifications (NMC) which has been show to be more powerful than other 
indicators, such as Q
2
, at detecting differences between groups
162
.  Cross-validation was 
conducted via cross-model validation, i.e. nested-CV, 2CV,
163
 wherein the dataset is 
randomly split into training and testing datasets (75%, 25%).  PLS-DA models were then 
generated from the training dataset and a leave-10-out internal cross-validation. 
Optimized models were used to predict the testing set (outer cross-validation).  Prediction 
accuracy is calculated from the resulting confusion matrix.  accuracy ≥ 85% and R2 
≥0.500 were considered potential models.  Model quality assessment was assessed by 
random permutation of group class with 1000 iterations where a low permutation p-value 
(>0.05) indicated a strong model.  Metabolites were subsequently ranked according to 
their respective variable importance of projection (VIP) score.  The highest VIP scores 
correspond to which metabolites contribute most to discrimination between groups.  The 
top 10 metabolites represent the primary drivers of the calculated discrimination. 
RESULTS 
Partial Least Squares Discriminant Analysis (PLS-DA) 
PLS-DA allowed discrimination between prefed and fasted state in this 
hemorrhagic shock model with changes most notable between the fed and fasted state in 
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the period of time between end of shock (S45) and 2 hours after full resuscitation (FR2).  
The final model statistics are reported in Table 1.  The majority of models reported 
accuracy ≥ 90% and R2 ≥ 0.500 (except FR8-FR2); however, not all models passed the 
permutation tests (Table 1).  The model comparing metabolite changes between baseline 
(B) and S45 was nearly significant (p=0.06) suggesting an alternate response to shock 
dependent upon fed state.  The model evaluating baseline metabolites provided high 
accuracy (90%) and R
2
 (0.586) but demonstrated a non-significant permutation (p = 
0.37).  The scoreplots generated from the S45-B and FR2-S45 PLSDA models provide 
clear separation between the groups (Figure 1). 
Important Metabolites 
The metabolites identified, by VIP scores, during the response to shock (S45-B) 
primarily reflected differing energy sources such as glycolysis in CPF animals 
(carbohydrate sugars, lactate) and amino acid metabolism in FS animals (aspartate, 
asparagine, 3-Hydroxyisovalerate).  In addition, some unexpected differences in elevated 
asparagine and adenosine were observed in CPF animals (Table 2).  VIP metabolites 
identified during the response to resuscitation (FR2-S45) continued to be associated with 
energy source differences (e.g. branch chain amino acid metabolism).  Indications of 
membrane repair (sn-Glycero-3-phosphocholine) and free radical scavenging (Benzoate) 
are also reported (Table 3).  Lineplots of the highest scoring metabolites are also 
provided in Figure 2. 
Given the high accuracy of each remaining model, selection of important 
variables was also performed via ranking metabolites by the VIP statistic (Appendix C - 
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Tables 1-2); however, strong conclusions could not be drawn from models not passing 
the permutation test. 
DISCUSSION 
In this article, we identify multiple differences in metabolism during shock and 
resuscitation associated with pre-injury fed state.  This discrimination was most notable 
during the initial response to shock and resuscitation with subsequent loss of 
discrimination over time suggesting the larger metabolic effect of shock and injury 
overcome the smaller metabolic effect of fed state. 
Response to Shock (S45-B) 
As expected, with a carbohydrate diet, immediately preceeding injury, liver tissue 
demonstrated a predominant glycolytic metabolism during the response to shock (S45-B) 
with active glucose, maltose and sucrose utilization followed by a dramatic increase in 
lactate levels.  Elevated lactate levels have been previously shown to be associated with 
poor outcome
164
.  The changes we observed in glucose metabolism compare to recently 
described measures of intracellular flux analysis of livers under fed and fasted states 
which reflect depleted glycogen stores in fasted livers
165,166
.  These reports suggest that 
maintaining glucose stores would be beneficial; however, these experiments consisted of 
animals undergoing burn injury and provided no survival measures.  Our data suggests 
that depleted glucose stores as a result of fasting may me protective following polytrauma 
and hemorrhagic shock.   
Aspartate also increases more rapidly in livers of CPF animals suggesting 
potentially impaired transport of the Malate-Aspartate shuttle leading to elevated 
aspartate levels and subsequent breakdown in the Urea cycle.  The Malate-Aspartate 
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shuttle is required for oxidative phosphorylation and therefore impairment may indicate a 
more severely stressed oxidative state.  The urea cycle enzymes may not be functioning 
as rapidly as in FS animals and this may be a consequence of the carbohydrate metabolic 
state, leading to a slower conversion to arginine leading to lower arginine and an 
accumulation of aspartate in CPF animals.  Aspartate can also be converted to asparagine, 
which also increased in CPF, and either recycled back to aspartate or excreted.  
VIP metabolites adenosine and arginine have been reported as protective prior to 
ischemia-reperfusion associated with Nitric Oxide (NO) metabolism
167,168
.  Adenosine is 
a potent vasodilator released as a response to ischemia-reperfusion
169
.  In addition, 
adenosine is the product of AMP degradation and is characteristic of an imbalance in the 
tissue oxygen supply/demand ratio.  Elevated levels of adenosine in CPF suggest a 
greater imbalance of oxygen.  Despite having elevated adenosine levels mean arterial 
pressure (MAP) is higher in CPF animals.  This may be explained as baseline levels of 
adenosine are essentially identical between FS and CPF animals whereas levels of 
arginine, another important vasodilator, are much higher in FS at S45 (CPF = 1.23mM, 
FS = 0.82mM, p-value = 9.6x10
-3
).  Prior literature reports that arginine is produced 
within the urea cycle, which is potentially upregulated by glucagon to handle increased 
proteolysis
170
. Our observations of elevated baseline BCAAs and continued decrease of 
leucine intermediate 3-Hydroxyisovalerate in FS animals during the response to shock 
adds support to this interpretation.   
Xanthine and glutathione were also identified as important metabolites.  Xanthine 
is the product of xanthine oxidoreductase and generates Reactive Oxygen Species (ROS).  
Initially xanthine levels were higher in FS animals, suggesting increased oxidative stress, 
75 
 
but decreased to levels similar to those in CPF animals during the response to shock.  The 
increasing xanthine levels in CPF animals is consistent with previous in vitro evidence 
idnetifying increased xanthine oxidase activity following prefeeding and ischemia but not 
following fasting
171
.  More recently, however, it has been suggested that ROS production 
by xanthine oxidase has limited importance in practice as the conversion of xanthine 
dehydrogenase to xanthine oxidase requires long ischemic periods that are rare in the 
clinical setting
172
.  This suggests that initial conditions (e.g. fed state) potentially 
precondition the xanthine oxidase activity prior ischemia.  Glutathione, an important 
antioxidant, also increases within CPF animals to modulate ROS.  Measurements of ROS 
species between fed states are needed to determine possible differences in oxidative 
stress. 
Response to Resuscitation (FR2-S45) 
During the response to resuscitation (FR2-S45) we found that fumarate declines 
sharply in the CPF animals.  This reduction is potentially a result of succinate 
dehydrogenase (i.e. Complex II) of the electron transport chain reducing fumarate to 
succinate during a period of reduced PaO2
173
.  This mechanism is supported by our data 
as succinate levels also increase (+0.05 ± 0.02mM) during the response to resuscitation.  
Curiously, lysine levels also increase in CPF but decrease in FS animals.  One possible 
explanation is the conversion of lysine to glutamine; an alternative substrate for the Krebs 
Cycle.  Our data reports elevated glutamine levels in CPF animals at FR2 (CPF = 
1.44mM, FS = 1.27mM, p-value = 0.09) which inhibit the conversion of glutamine 
synthase, the final step between lysine and glutamine, resulting in elevated lysine 
levels
174
. 
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Metabolism in FS animals continues to reflect BCAA degradation, in which 
valine, leucine, and isoleucine levels are all decreasing but remain higher indicating 
continued protein breakdown.  However, increasing levels of 3-Hydroxyisovalerate (i.e. 
β-Hydroxy-β-methylbutryate, HMB) in FS animals suggests impaired complete leucine 
degradation.  Prior research on muscle has reported 3-Hydroxyisovalerate as a substrate 
for HMG-CoA reductase, an important enzyme for cholesterol synthesis to stabilize 
membrane integrity
175
.  To our knowledge there is no literature exploring 3-
Hydroxyisovalerate and HMG-CoA in the liver.   It is also noted that sn-Glycero-3-
phosphocholine (i.e. Glycerophosphocholine, GPC) levels decreased more rapidly in FS 
relative to CPF animals.   GPC is indicative of membrane maintenance and repair
46
.  This 
is supported by a slight increase in Choline levels, potentially being quickly incorporated 
into membranes.   
The hypoxic state following hemorrhagic shock and the subsequent reperfusion 
results in the production of reactive oxygen species (ROS).  Interestingly, our data reports 
higher benzoate concentration, an oxygen radical scavenger
176,177
, in FS animals (Table 
3).  One potential mechanism is that CPF animals experience greater oxidative stress 
following anaerobic glycolysis, as noted by prior xanthine levels, where increased 
antioxidants would prove beneficial; however assays of ROS need to be pursued 
comparing fed states for definitive conclusions.  To our knowledge, no previous research 
has reported benzoate as a radical scavenger following reperfusion.  It is possible that the 
conversion of benzoate to hippurate for excretion is inhibited resulting in the observed 
increase, however, further research is needed to determine if this is an alternate 
antioxidant following reperfusion.  
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Although this study measured a large number of metabolites, this study is limited 
by the both the extraction method and tissue utilized.  The PCA method only extracts 
water soluble metabolites and there may be other compounds that could reflect other 
altered metabolic processes.  An investigation using alternate extraction techniques 
would prove valuable.  The liver is only one component of the systemic response to 
hemorrhagic shock and resuscitation and analysis of other compartments such as serum, 
urine and muscle would be beneficial.   
CONCLUSIONS 
The liver metabolic response to shock is initially significantly different depending 
upon fed state.  This difference dissipates over time as the effects of injury overwhelm 
the effects of prefeeding.  Our identification of VIP metabolites validated previously 
expected changes in metabolism between carbohydrate prefed and fasted animals such as 
alternate carbon energy sources.  In addition, metabolites associated with NO production, 
branched chain amino acid metabolism, oxidative stress, and membrane maintenance 
were significantly different between carbohydrate prefed and fasted animals during the 
response to shock and response to resuscitation.   This analysis reveals that fed state has 
defined implications on the response to hemorrhagic shock and injury and thereby 
provides some clues about how future therapeutics should be modified.  Exploring other 
pre-feeding methods, such as protein or lipid, would provide further useful information 
concerning the response to shock. 
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MODEL R2 NMC ± SD ACCURACY (% 
correct classified 
PERMUTATION 
(p-value) 
B .586 2.8 ± 1.5 95 .37 
S45-B .614 2.8 ± 1.3 95 .06 
FR2-S45 .727 2.0 ± 1.1 95 .04 
FR8-FR2 .495 4.1 ± 1.2 90 .64 
FR20-FR8 .540 4.0 ± 1.3 90 .60 
Table 1: Results of PLS-DA model generation for each timepoint/difference.  
Abbreviations: NMC (Number of Misclassified), SD (Standard Deviation)  
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Metabolite 
VIP 
Score Group 
S45 
Mean±SE 
Difference 
Mean±SE 
Mann-
Whitney 
U 
Glucose 3.301 CPF 25.69±2.68 191.18±27.83 
p=5.9x10
-9 
FS 5.62±0.99 -2.27±6.85 
Lactate 2.237 CPF 5.58±0.45 39.81±4.65 
p=8.1x10
-4 
FS 3.42±0.28 18.14±3.44 
Aspartate 2.042 CPF 1.09±0.07 3.02±0.79 
p=4.3x10
-3 
FS 0.82±0.05 -0.21±0.56 
Maltose 1.993 CPF 1.30±0.28 -12.31±3.05 
p=2.1x10
-5 
FS 0.25±0.04 -2.08±0.80 
Sucrose 1.967 CPF 0.76±0.16 -7.96±1.86 
p=2.8x10
-3 
FS 0.14±0.02 -1.72±0.61 
Glutathione 1.412 CPF 1.74±0.17 3.47±1.71 
p=0.168 
FS 1.38±0.12 -1.68±1.61 
Xanthine 1.391 CPF 0.05±0.01 0.08±0.06 
p=0.109 
FS 0.06±4x10
-3 
-0.12±0.07 
Asparagine 1.375 CPF 0.35±0.06 1.01±0.47 
p=0.131 
FS 0.27±0.03 -0.34±0.43 
Adenosine 1.296 CPF 0.28±0.04 1.11±0.31 
p=0.032 
FS 0.21±0.02 0.34±0.23 
3-Hydroxyisovalerate 1.117 CPF 0.07±0.01 0.08±0.04 
p=0.124 
FS 0.07±0.01 -0.08±0.07 
 
Table 2: Mann-Whitney U results of the top 10 VIP (Variable Importance of Projection) 
metabolites to discriminate Fasted and Carbohydrate Prefed (CPF) samples during the 
response to shock (S45-B) via PLS-DA.  Mean concentrations reported as µM ± SE 
(standard error). 
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Metabolite 
VIP 
Score 
Group 
FR2 
Mean±SE Mean±SE 
Mann-
Whitney 
U 
Glucose 3.311 CPF 7.40±0.66 -
148.38±24.59 p=9.5x10
-6 
FS 5.38±0.31 -4.83±11.85 
3-Hydroxyisovalerate 2.083 CPF 0.07±0.01 -0.02±0.03 
p=2.7x10
-3 
FS 0.08±0.01 0.13±0.04 
Valine 1.659 CPF 0.23±0.02 -1.15±0.31 
p=0.057 
FS 0.30±0.02 -2.40±0.43 
Fumarate 1.658 CPF 0.05±0.01 -0.26±0.04 
p=0.011 FS 0.05±3x10
-
3 
-0.08±0.08 
Benzoate 1.639 CPF 0.15±0.03 -0.03±0.24 
p=8.3x10
-3 
FS 0.22±0.03 0.81±0.30 
Leucine 1.590 CPF 0.25±0.03 -1.43±0.32 
p=0.094 
FS 0.28±0.02 -2.50±0.36 
Choline 1.367 CPF 0.63±0.16 0.66±1.19 
p=0.068 
FS 0.47±0.06 -1.94±0.87 
Isoleucine 1.364 CPF 0.14±0.02 -0.63±0.22 
p=0.146 
FS 0.18±0.01 -1.19±0.21 
Lysine 1.356 CPF 1.08±0.12 1.12±1.05 
p=0.099 
FS 1.03±0.12 -1.60±1.07 
Sn-Glycero-3-
phosphocholine 
1.390 CPF 5.20±0.48 -26.06±4.84 
p=0.080 
FS 3.46±0.42 -39.36±5.37 
 
Table 3: Mann-Whitney U results of the top 10 VIP (Variable Importance of Projection) 
metabolites to discriminate Fasted and Carbohydrate Prefed (CPF) samples during the 
response to resuscitation (FR2-S45) via PLS-DA.  Mean concentrations reported as µM ± 
SE (standard error). 
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Figure 1 – 2D score plots of response to shock (S45-B) and resuscitation (FR2-S45) PLS-
DA models visually representing the discrimination between groups. Green represents 
Fasted animals and Blue represents Carbohydrate Prefed animals. 
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Figure 2 – Lineplots of Glucose, Lactate, 3-Hydroxyisovalerate and Aspartate 
  
83 
 
CHAPTER 8 
 
Fed State Prior to Hemorrhagic Shock and Polytrauma in a Porcine Model Results in 
Altered Liver Transcriptomics Response 
84 
 
ABSTRACT 
 Hemorrhagic shock is a leading cause of trauma-related mortality in both civilian 
and military settings.  Resuscitation often results in reperfusion injury and survivors are 
susceptible to developing multiple organ failure (MOF).  The impact of fed state on the 
overall response to shock and resuscitation (HS/R) has been explored in some murine 
models but few clinically relevant large animal models.  We have previously used 
metabolomics to establish that the fed state results in a different metabolic response in the 
porcine liver following HS/R.  In this study, we used our clinically relevant model of 
hemorrhagic shock and polytrauma and the Illumina HiSeq platform to determine if the 
liver transcriptomic response is also altered with respect to fed state.  Functional analysis 
of the response to shock and resuscitation confirmed several typical responses including 
carbohydrate metabolism, cytokine inflammation, decreased cholesterol synthesis, and 
apoptosis.  Our findings also suggest that the fasting state, relative to a carbohydrate 
prefed state, displays decreased carbohydrate metabolism, increased cytoskeleton 
reorganization and decreased inflammation in response to hemorrhagic shock and 
reperfusion.  Evidence suggests that this is a consequence of a shrunken, catabolic state 
of the liver cells which provides an anti-inflammatory condition that partially mitigates 
hepatocellar damage.   
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INTRODUCTION 
Hemorrhagic shock is a leading cause of trauma-related mortality in both civilian 
and military settings.  Efforts over the years have significantly improved survival in the 
military sector
150
;  however, hemorrhagic shock from traumatic injury results in multiple 
alterations in the metabolic state of an organism many of which are not fully elucidated.  
Civilian data estimates between 1400 and 14,000 preventable hemorrhagic trauma deaths 
occur per year in the United States
151
.  Military data has consistently reported 
hemorrhagic shock as the leading cause of preventable deaths
152–154
. 
Hemorrhagic shock results in inadequate tissue perfusion leading to decreased 
oxygen availability to mitochondria.  This condition causes a switch towards anaerobic 
metabolism in addition to a complex inflammatory response.  The liver serves an 
important function as a regulator of metabolism during stressed states.  Initially, the shift 
towards anaerobic metabolism stimulates the liver to increase glycogenolysis and process 
elevated lactate produced in the peripheral tissues.  The liver also provides a major site of 
detoxification and production of alternate metabolic fuel sources including amino acids 
and lipids.   
Previous research in our laboratory revealed increased acute lung injury and 
multiple organ failure with a trend toward increased mortality in pigs receiving a 
carbohydrate prefeed prior to hemorrhagic shock relative to fasted pigs
155
.  Our previous 
metabolomics research has reported an altered response to fed state in the liver and urine 
as well as phase of care in serum following hemorrhagic shock and resuscitation
42,95,112
.  
The objective of this study was to determine if this differential response is related to 
varied genetic expression in the liver with the hypothesis that there would be quantifiable 
86 
 
differences in liver mRNA expression reflecting an altered response to shock and 
resuscitation with respect to fed state.  To test this hypothesis, we used our well-
established model of hemorrhagic shock and polytrauma comparing the effect of 
providing a carbohydrate prefeed (CPF) versus a fasted (FS) diet prior to insult.  
Extraction of mRNA from liver biopsies and subsequent RNA-Sequencing was used to 
compare between CPF and FS animals at four timepoints: Baseline (B), and 2, 8 and 20 
hours after resuscitation (FR2, FR8, and FR20).  Secondly, livers samples were examined 
over the course of polytrauma, hemorrhagic shock and resuscitation within each group to 
determine how mRNA expression changed within each group.   
MATERIALS AND METHODS 
Animal Preparation and Hemorrhagic Shock Protocol 
Sixty four (64) juvenile, male Yorkshire pigs were used in this study.  All animals were 
fasted overnight.  Two experimental groups were utilized: Carbohydrate Prefed (CPF, n = 
32) and Fasted (FS, n = 32).  CPF animals were given 7cc/kg bolus of Karo Syrup
®
 
(mixture of sugars including ~ 15% glucose, maltose, fructose and sucrose) diluted with 
water 1 hour prior to induction.  The full experimental polytrauma and shock protocols 
have been described in detail previously
46,112
.  Briefly, animals were instrumented and 
splenectomized.  Polytrauma was induced by a captive bolt device to create a blunt 
percussive injury to the chest and a liver crush injury using a Holcomb clamp 
technique
20
.  Hemorrhagic shock was then induced by withdrawal of blood from the 
inferior vena cava until a systolic pressure of 45 to 55mmHg was reached for 45 minutes 
(S45) to simulate time prior to medical help.  Typically, this resulted in withdrawal of 
approximately 40% of the pig’s blood volume.  Blood was placed in an acid-citrate-
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dextrose bag for later use.  Following the shock period, animals received lactated 
Ringer’s fluid given as 20 cc/kg intravenous (IV) boluses to maintain a systolic blood 
pressure greater than 80 mmHg for one hour of limited resuscitation to simulate 
transportation to a medical center; then underwent full resuscitation protocol for the 
following 24 hours (Appendix A).  This resuscitation included fluid, shed blood, and 
ventilator support in a protocolled fashion.  After the resuscitation period, animals were 
extubated and sent to recovery and subsequently euthanized. 
 At several time points throughout the experiment, liver biopsies were taken from 
the periphery of the liver ranging in weight from 0.2 to 0.6 grams.  Biopsies were flash 
frozen in liquid nitrogen and stored at -80°C until preparation for RNA extraction.  
Biopsies were taken at the following timepoints: baseline after the animal stabilized from 
instrumentation (B), 45 minutes after hemorrhage (S45), 2, 8, and 20 hours after full 
resuscitation (FR2, FR8, FR20).  RNA extractions and sequencing were conducted on B, 
FR2, FR8, and FR20.  Analysis was not conducted on the S45 timepoint because of the 
short time period from baseline to allow RNA changes to take place. 
RNA Preparation and Sequencing 
RNA Extraction and Quality Assessment.  In a previous study, some of the samples from 
the original 64 animals had been utilized.  As such, only those that had all consecutive 
timepoints were included.  Ultimately, only 18 Fasted animals and 5 Prefed animals were 
analyzed at each timepoint (total n = 92).  RNA was purified from liver samples using 
QIAshredder and Qiagen RNeasy Mini Kits (Qiagen, Chatsworth, CA).  Total RNA 
isolates were quantified using a fluorimetric RiboGreen assay.  Total RNA integrity was 
assessed using capillary electrophoresis, generating an RNA Integrity Number (RIN).  
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All of the samples were verified as high quality (>1 microgram, RIN = 8+) and thus were 
converted to Illumina sequencing libraries. 
Library Creation.  RNA samples were converted to sequencing libraries using Illumina’s 
Truseq RNA Sample Preparation Kit (RS-122-2001).  In brief, 1 microgram of total RNA 
was enriched for mRNA using oligo-dT coated magnetic beads, fragmented, and reverse 
transcribed in cDNA.  The cDNA was fragmented into smaller pieces blunt-ended, and 
ligated to indexed adaptors and amplified using 15 cycles of PCR.  Final library size 
distribution was validated using capillary electrophoresis and quantified using PicoGreen 
fluorimetry and qPCR.  Libraries were successfully sequenced for all samples. 
Cluster generation and sequencing.  Truseq libraries were hybridized to a paired-end 
flow cell and individual fragments were clonally amplified by bridge amplification on the 
Illumina cBot.  Libraries were clustered at a concentration of 12 pM.  The flow cell was 
then loaded on the HiSeq 2000 and sequenced using Illumina’s Sequencing by Synthesis 
(SBS) chemistry.  Upon completion of a read, a 7 base pair index was performed for 
sample identification.  Samples were run for 100 cycles with 10 million single reads per 
sample. 
Primary analysis and de-multiplexing.  Base call (.bcl) files for each cycle of sequencing 
were generated by Illumina Real Time Analysis software.  The base call files and run 
folders were then exported to servers maintained at the Minnesota Supercomputing 
Institute (Minneapolis, MN).  Primary analysis and de-muliplexing were performed using 
Illumina’s CASAVA software 1.8.2, resulting in de-multiplexed FASTQ files. 
Bioinformatics and Data Analysis 
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RNA-Seq read sequences produced by the Illumina HiSeq 2000 were aligned with the 
TopHat software
69
 to the NCBI Sscrofa 10.2 reference genome.  The BAM files from the 
TopHat mapping were sorted using SAMtools
178
 and raw counts estimated by the Python 
script HTSeq count (http://www.-huber.embl.de/users/anders/HTSeq/)using the NCBI 
Sscrofa 10.2 reference genome.  Identified contigs were converted to human orthologs 
with the BiomaRt Bioconductor package
179
 which facilitates access to BioMart 
annotation resources
180
.  Gene names used for identification are the official Human 
Genome Organization (HUGO) Gene Nomenclature Committee (HGNC) designations. 
The resulting raw counts per gene were used by EdgeR
64
 to estimate differential 
expression (DE).  EdgeR (Bioconductor release 3.2.4) uses a pair-wise design to measure 
differential expression. The analysis is based on a negative binomial model that uses 
over-dispersion estimates to account for biological variability (i.e., sample to sample 
differences); this is an alternative to the Poisson estimates of biological variability that 
are often inappropriate
181
. Genes with less than 10 reads were excluded from the analysis 
and TMM normalization of the sequenced libraries was performed to remove effects due 
to differences in library size
182
.  The most stringent dispersion method (tag-wise) was 
used to ensure that differential expression was not due to individual differences.  EdgeR 
generates a log2 fold change for each gene, p values and the Benjamini-Hochberg false 
discovery rate (FDR) are calculated to statistically test the measured DE. Lastly, genes 
were filtered to those reporting log2 fold changes ≥ 1 or ≤ -1 (i.e. 2 fold change).  
Gene Ontology Analysis 
The differentially expressed transcripts calculated between fed states at each time point 
(e.g. FSvCPF, FR2) and between timepoints within each group (e.g. FR8vB, FS) were 
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analyzed using the functional annotation tools of DAVID
85,88
 and additional literature 
searches.  Lists of DEGs from each comparison were entered into DAVID in addition to 
the complete list of sequenced genes to serve as background for analysis.  DAVID 
analysis provides both functional annotations of each gene (Functional Annotation Table) 
and of each list of genes (Functional Annotation Clustering) to provide functional 
information using gene ontology
83
.  The Functional Annotation Clustering tool provides 
an overall picture of the overrepresented and enriched functions by consolidating 
redundancies in gene ontology categories.  Information on specific genes was obtained 
using the Functional Annotation Table tool and the scientific literature.  
RESULTS 
RNA-Sequencing Quality 
The RNA-sequencing (RNA-seq) results from the Illumina HiSeq 2000 were 
output as FASTQ format and mapped to the NCBI Sscrofa 10.2 release of the pig genome 
(ftp://ftp.ncbi.nih.gov/genbank/genomes/Eukaryotes/vertebrates_mammals/Sus_scrofa/Ss
crofa10.2/) using TopHat
69
.  One FR8 sample failed to sequence successfully and was 
omitted from further analysis.  For each sample, approximately 11.8 million reads were 
generated (range, 6.9 to 20.6 million reads).  On average 88.8% of the reads generated 
were mapped uniquely (range, 85.7 – 98.3 percent mapped).  Following conversion to 
human orthologs and Human Gene Nomenclature Committee (HGNC) notation, to 
facilitate functional analysis, we identified 16,498 genes. The raw data has been made 
available through the Gene Expression Omnibus database accession number GSE55674. 
Differentially Expression 
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 We initially compared gene expression differences between CPF and FS animals 
at Baseline.  Of the 16,498 genes, 68 were identified as differentially expressed genes 
(DEGs) with 14 upregulated and 54 downregulated in CPF relative to FS.  In addition, 
subsequent analysis comparing each timepoint relative to baseline between CPF and FS 
identified 13, 29, and 30 DEGs at FR2, FR8 and FR20 versus baseline respectively.  At 
each time point following resuscitation, all DEGs were higher in CPF compared to FS 
except 2 genes at FR20 versus baseline (CHKA and GCK) (Supplementary File 1). 
 We then compared gene expression differences between each time point and 
baseline within each fed state.  Within carbohydrate prefed animals 116, 478, and 0 
DEGs were identified at FR2, FR8, and FR20 timepoints versus baseline respectively 
(Supplementary File 2).  Observed gene expression changes in fasted animals was far 
more extensive as 1442, 1460, and 1215 DEGs were identified at FR2, FR8 and FR20 
timepoints versus baseline respectively (Supplementary File 3).  Table 1 summarizes the 
DEGs for all comparisons (FDR<0.05).   
Functional Analysis – Fed State Expression 
Analysis of the differentially expressed transcripts using the Database for 
Annotation, Visualization and Integrated Discovery (DAVID)
85
 and accompanying 
literature searches provided an overall picture of the overrepresented functions between 
the two fed states at various time points (Supplementary File 4).  As expected, 
comparisons at baseline provide evidence of upregulation of transcripts important for 
carbohydrate metabolism in CPF animals.  Curiously, the majority of the differences 
were related to contractile proteins associated with the cytoskeleton.  Prior literature 
supports this observation in that cytoskeletal proteins, such as actin, are elevated in 
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response to glucagon and cellular shrinkage
183–185
.  However, these previous studies 
report even greater actin mRNA expression in response to insulin, which stimulates 
cellular swelling, suggesting that elevated carbohydrates more strongly induce 
cytoskeleton remodeling.  In contrast to these studies, which were cell based, our in vivo 
investigation reports higher actin mRNA in fasted animals at baseline.  This trend 
reverses during FR2, FR8 and FR20 where cytoskeletal proteins in CPF exceed FS 
animals (Figure 1). 
Functional Analysis – Responses to Shock and Resuscitation within each Fed State 
Carbohydrate Prefed - FR2 v. Baseline 
Analysis of each timepoint relative to baseline within CPF animals revealed 
several responses that are characteristic of hemorrhagic shock and resuscitation.  Analysis 
of FR2vB identified functional responses including increases in processes associated with 
cell adhesions, hormone responses and cell membrane processes (Supplementary File 5).  
Exploration of the genes within these categories revealed activation of gene expression 
related to evidence of wound healing, and apoptosis. 
Carbohydrate Prefed - FR8 v. Baseline 
 Continued resuscitation in CPF animals continued to identify gene expression 
characteristic of the response to hemorrhagic shock and resuscitation.  Functional clusters 
identified included altered cytokine production (Figure 3), lipid metabolism (Figure 4), 
oxidation-reduction processes, hormone responses, and peptidase activity (Figure 5) 
(Supplementary File 5).  Genes associated with cytokine production included heat shock 
60kDa protein 1 (HSPD1) and myeloid differentiation primary response 88 (MyD88) 
which both induce pro-inflammatory cytokines
186–188
.  Analysis of specific genes within 
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categories suggested decreased cholesterol synthesis, decreased fatty acid beta-oxidation 
and apoptosis.  All processes are typical following ischemia-reperfusion
189,190
.  No genes 
were found to be significant when comparing FR20 to baseline, possibly a consequence 
of the small sample size in the CPF group. 
Fasted – FR2 v. Baseline 
 Functional analysis of resuscitation in FS animals returned 37 clusters of similar 
processes to CPF animals including cell adhesions, wound healing, cytokine 
inflammation and apoptosis (Supplementary File 6).  In contrast to CPF animals, 
cytoskeleton reorganization appears to be taking place wherein cytoskeletal genes are 
decreasing (Figure 1).  This finding is concordant with previous reports of cytoskeleton 
destabilization following reperfusion
191
. 
Fasted – FR8 v. Baseline 
 Following 8 hours of resuscitation FS, functional analysis identified 45 clusters 
that were very similar to CPF animals.  The processes include cytokine inflammation, 
decreased cholesterol synthesis, and apoptosis (Supplementary File 6).  In addition, 
cytoskeleton reorganization continues to take place as noted by decreasing cytoskeletal 
gene expression including actin and multiple elevated myosin heavy and light chains 
(MYH1, MYH2, MY3, MY6, MY7, MY13, MYL1, MYL2, MYL3) (Figure 6).  In 
addition, glycolysis appears to be downregulated as several glycolytic genes decreased 
(HK2, PGAM2, ENO3, GPD2, PDK2, PFKM, and PKLR) (Figure 7). 
Fasted – FR20 v. Baseline 
 Lastly, of the 41 clusters identified by functional analysis following 20 hours of 
resuscitation primary processes continued to include cytoskeleton reorganization in 
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addition to ion transport and glucose metabolism processes (Supplementary File 6).  
Genes associated with glycolytic and ion transport processes continue to both be 
decreased relative to baseline (Figures 7 & 8).  Cholesterol and lipid oxidation are also 
decreased in overall expression (Figure 9). 
DISCUSSION 
We report that the primary differences between the liver transcriptomic response 
to hemorrhagic shock between fasted and carbohydrate prefed pigs during the first 24 
hours in a polytrauma model of hemorrhagic shock and resuscitation consist of glucose 
metabolism and cytoskeletal remodeling.  Consistent with known changes associated 
with ischemia and reperfusion, we also found evidence of cytokine activation, apoptosis, 
and lipid metabolism ontological categories.  Additionally, genes associated with 
increased pro-inflammatory cytokines were elevated in CPF animals relative to FS 
animals.  Our results suggest the anti-inflammatory state of the FS animals may be a 
result of the fasting metabolic state. 
Gene Ontology Profiles 
 We present the first, to our knowledge, comprehensive exploration of the pig liver 
transcriptome following a polytrauma model of hemorrhagic shock and resuscitation via 
RNA-seq.  As expected following a carbohydrate prefeed genes associated with 
carbohydrate metabolism were upregulated as indicated by elevated Glucokinase (GCK) 
and glycogen phosphorylase (PYGM) in CPF and FS animals respectively reflecting the 
alternate metabolic state wherein fasted animals are releasing glucose and CPF animals 
are breaking down available glucose. 
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 The difference in cytoskeleton related genes in FS animals compared to CPF and 
over time suggests a link between fed state and metabolic response to hemorrhagic shock 
and resuscitation.  Prior in vitro investigations have reported that glucagon, which is 
elevated during fasting periods, causes cellular shrinkage as a result of altered ion 
fluxes
192,193
.  Conversely, elevated insulin results in cellular swelling.  Typically, upon 
swelling, a cell will trigger volume regulatory K
+
 efflux.  In contrast, following cellular 
shrinkage, it becomes important for the cell to retain ions.  Decreased ion transport is 
seen in our fasted animals, including several KCN family members (Figure 8), whereby 
the cells have previously shrunk in response to fasting and possibly don’t require 
additional ion transporters.   Additionally, glucagon stimulates the transcription of actin 
followed by assembly of actin filaments
183–185
.  Contrary to these in vitro studies, 
however, our in vivo investigation reports increased actin transcription in fasted animals 
compared to CPF animals.  This cellular shrinkage has been previously described as 
triggering the ‘catabolic state’ of a cell resulting in a multitude of altered processes194.  
The presence of this cytoskeleton remodeling is further supported in our study by 
upregulation of contractile proteins including multiple myosins for intracellular transport.  
In addition, cellular swelling stabilizes actin filaments
195
 which helps explain why 
cytoskeleton mRNA expression is higher in CPF than FS during resuscitation which 
usually results in actin depolymerization
196
. 
 Previous studies elucidating the impact of cell swelling during ischemia and 
reperfusion report that cells naturally become hyperosmotic during ischemia and 
consequently take up additional fluid
197,198
.  This increased swelling and resultant cellular 
edema may compress capillaries thereby reducing or preventing reperfusion of capillary 
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beds
199–201
.  This process results in zones that prevent reperfusion resulting in the ‘no-
reflow’ phenomenon202.  It is possible that the fasting state displays a shrunken catabolic 
state that may provide an initial condition to partially mitigate the subsequent swelling 
that is an unavoidable consequence of ischemia and reperfusion.  The benefit of induced 
cellular shrinkage on hepatocellular injury has been shown previously whereby 
hypertonic preconditioning (i.e. induced cellular shrinkage) reduces hepatocellular 
damage following ischemia reperfusion
203
.  Furthermore, the use of hypertonic saline for 
reperfusion has been shown to decrease susceptibility to sepsis, mitigate inflammation, 
and reduce apoptosis after hemorrhagic shock
204–206
 in addition to being attractive for 
small-volume resuscitation development
153
. 
 The full molecular mechanisms behind the proposed state are not fully elucidated 
however several components are understood.  One direct result of cellular shrinkage is 
vasodilation potentially mediating the no-reflow condition.  Furthermore, cellular 
shrinkage is a consequence of hypertonic treatments which have been shown mitigate 
inflammation following shock
207,208
.  The hyperosmotic environment causes cellular 
shrinkage which activates the tyrosine phosphorylation of Janus kinases. These kinases 
activate the transcription factor STAT3
209
 which ultimately stimulates Interleukin 10 (IL-
10) production while simultaneously inhibiting pro-inflammatory cytokines (e.g. IL-1β, 
TNF-α, and intercellular adhesion molecules) by inhibiting the transcription factor NF-
κB210,211 (Figure 10).  Although IL-10 was not individually identified, the anti-
inflammatory state of the FS is supported as several pro-inflammatory genes are elevated 
in CPF animals (Figure 8).  Further research on the anti-inflammatory properties of 
cellular shrinkage is required. 
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Although this study utilized a larger sample size, our groups were unbalanced (18 
versus 5).  This difference in group size may have partially biased estimates.  However, 
given the quality of the RNA-seq, consistency across timepoints, and agreement with 
supporting literature supports our results.  Lastly, it is important to recall that the liver is 
only one component of the overall systemic response to hemorrhagic shock and 
resuscitation.  Analysis of other organs and tissues would be should be pursued.   
CONCLUSION 
 Analysis of the liver transcriptome between carbohydrate prefed and fasted pigs 
following hemorrhagic shock and resuscitation reveals that the first 24 hours results in 
different changes to the cytoskeleton structure.  Our results suggest this both a metabolic 
response to decreased carbohydrate substrates and structural modifications in response to 
cellular shrinkage.  Further evidence suggests that this shrunken state provides an anti-
inflammatory condition that may decrease hepatocellar damage.  More work is required 
to investigate the potential benefits of alternative diets such as the anti-inflammatory 
effects of increased intake of omega-3 fatty acids. 
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Comparison Differentially Expressed Genes 
CPFvFS, B 68 
CPFvFS, FR2vB 13 
CPFvFS, FR8vB 29 
CPFvFS, FR20vB 30 
FR2vB, CPF 116 
FR8vB, CPF 478 
FR20vB, CPF 0 
FR2vB, FS 1442 
FR8vB, FS 1460 
FR20vB 1215 
 
Table 1 – Number of differentially expressed genes between CPF and FS animals and between 
timepoints within groups.  Abbreviations: CPF (Carbohydrate Prefed), FS (Fasted), B (Baseline), 
FR2, FR8 and FR20 (2, 8 and 20 hours after full resuscitation). 
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Figure 1 – Heatmap of log2 fold changes of genes associated with cytoskeleton processes 
between carbohydrate prefed (CPF) and fasted (FS) animals.  Rows are differentially expressed 
genes (DEGs) following RNA sequencing.  Columns are denote the respective timepoints 
Baseline (B), 2 hours full resuscitation change from Baseline (FR2vB), 8 hours full resuscitation 
change from Baseline (FR8vB), and 20 hours full resuscitation change from Baseline (FR20vB).  
Green denotes higher concentration or larger changes in mRNA concentration in CPF whereas 
red denotes the opposite. 
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Figure 2 – Heatmap of log2 fold changes of genes associated with carbohydrate metabolism 
between carbohydrate prefed (CPF) and fasted (FS) animals.  Rows are differentially expressed 
genes (DEGs) following RNA sequencing.  Columns are denote the respective timepoints 
Baseline (B), 2 hours full resuscitation change from Baseline (FR2vB), 8 hours full resuscitation 
change from Baseline (FR8vB), and 20 hours full resuscitation change from Baseline (FR20vB).  
Green denotes higher concentration or larger changes in mRNA concentration in CPF whereas 
red denotes the opposite. 
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Figure 3 – Heatmap of log2 fold changes of genes associated with cytokine related genes in 
carbohydrate prefed (CPF) animals at each resuscitation timepoint (2, 8, and 20 hours) relative to 
Baseline (B).  Rows are differentially expressed genes (DEGs) following RNA sequencing.  
Columns are denote the respective timepoints Baseline (B), 2 hours full resuscitation change from 
Baseline (FR2vB), 8 hours full resuscitation change from Baseline (FR8vB), and 20 hours full 
resuscitation change from Baseline (FR20vB).  Green denotes increased mRNA expression 
whereas red denotes the opposite. 
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 Figure 4 – Heatmap of log2 fold changes of genes associated with lipid metabolism in 
carbohydrate prefed (CPF) animals at each resuscitation timepoint (2, 8, and 20 hours) relative to 
Baseline (B).  Rows are differentially expressed genes (DEGs) following RNA sequencing.  
Columns are denote the respective timepoints Baseline (B), 2 hours full resuscitation change from 
Baseline (FR2vB), 8 hours full resuscitation change from Baseline (FR8vB), and 20 hours full 
resuscitation change from Baseline (FR20vB).  Green denotes increased mRNA expression 
whereas red denotes the opposite. 
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Figure 5 – Heatmap of log2 fold changes of genes associated with peptidase activity in 
carbohydrate prefed (CPF) animals at each resuscitation timepoint (2, 8, and 20 hours) relative to 
Baseline (B).  Rows are differentially expressed genes (DEGs) following RNA sequencing.  
Columns are denote the respective timepoints Baseline (B), 2 hours full resuscitation change from 
Baseline (FR2vB), 8 hours full resuscitation change from Baseline (FR8vB), and 20 hours full 
resuscitation change from Baseline (FR20vB).  Green denotes increased mRNA expression 
whereas red denotes the opposite. 
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Figure 6 – Heatmap of log2 fold changes of genes associated with cytoskeleton processes in 
fasted (FS) animals at each resuscitation timepoint (2, 8, and 20 hours) relative to Baseline (B).  
Rows are differentially expressed genes (DEGs) following RNA sequencing.  Columns are 
denote the respective timepoints Baseline (B), 2 hours full resuscitation change from Baseline 
(FR2vB), 8 hours full resuscitation change from Baseline (FR8vB), and 20 hours full 
resuscitation change from Baseline (FR20vB).  Green denotes increased mRNA expression 
whereas red denotes the opposite. 
  
106 
 
 
Figure 7 – Heatmap of log2 fold changes of genes associated with carbohydrate metabolism in 
fasted (FS) animals at each resuscitation timepoint (2, 8, and 20 hours) relative to Baseline (B).  
Rows are differentially expressed genes (DEGs) following RNA sequencing.  Columns are 
denote the respective timepoints Baseline (B), 2 hours full resuscitation change from Baseline 
(FR2vB), 8 hours full resuscitation change from Baseline (FR8vB), and 20 hours full 
resuscitation change from Baseline (FR20vB).  Green denotes increased mRNA expression 
whereas red denotes the opposite. 
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Figure 8 – Heatmap of log2 fold changes of genes associated with ion transport in fasted (FS) 
animals at each resuscitation timepoint (2, 8, and 20 hours) relative to Baseline (B).  Rows are 
differentially expressed genes (DEGs) following RNA sequencing.  Columns are denote the 
respective timepoints Baseline (B), 2 hours full resuscitation change from Baseline (FR2vB), 8 
hours full resuscitation change from Baseline (FR8vB), and 20 hours full resuscitation change 
from Baseline (FR20vB).  Green denotes increased mRNA expression whereas red denotes the 
opposite. 
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Figure 9 – Heatmap of log2 fold changes of genes associated with carbohydrate metabolism in 
fasted (FS) animals at each resuscitation timepoint (2, 8, and 20 hours) relative to Baseline (B).  
Rows are differentially expressed genes (DEGs) following RNA sequencing.  Columns are 
denote the respective timepoints Baseline (B), 2 hours full resuscitation change from Baseline 
(FR2vB), 8 hours full resuscitation change from Baseline (FR8vB), and 20 hours full 
resuscitation change from Baseline (FR20vB).  Green denotes increased mRNA expression 
whereas red denotes the opposite. 
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Figure 10 – Diagram of simplified Interleukin-10 (IL-10) pathway.  A hyperosmotic condition 
induces cellular shrinkage and activates tyrosine phosphorylation of Janus kinases (JAK) to 
subsequently phosphorylate STAT3 and IL-10 production. 
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CHAPTER 9 
 
Conclusions 
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Concluding Remarks 
Hemorrhagic shock, following trauma, has continued to be a leading cause of 
death in both military and civilian settings. This public health interest has spurred 
research over decades leading to improvements in treatment.  However, the metabolic 
mechanisms altered in response to shock and subsequent resuscitation require further 
understanding to not only treat patients post-injury but potentially also advance pre-
conditioning strategies to mitigate potential injury in the military sector. Transcriptomics 
is an established sub-discipline of systems biology that can profile altered genome level 
processes and provide insight into overall physiologic responses.  Metabolomics is an 
additional and rapidly growing sub-discipline of systems biology that facilitates the 
identification of altered pathways and biomarker identification.  Together, these two 
systems biology approaches applied towards hemorrhagic shock facilitate advancements 
in the understanding of the numerous complex responses to injury.  The focus of this 
dissertation has been to evaluate current approaches towards analyzing metabolomics 
data (Chapter 6) and analyze the impact of fed state on both the metabolomic (Chapter 7) 
and transcriptomic (Chapter 8) response to hemorrhagic shock and resuscitation.  
Herein, established NMR and RNA-sequencing techniques were applied explore 
the metabolomic and transcriptomic responses, respectively, within our clinically 
relevant, porcine model of hemorrhagic shock and resuscitation. The response to 
hemorrhagic shock and resuscitation is a complex process consisting of multiple systemic 
changes.  Metabolomic and transcriptomic techniques facilitate the analysis of these 
systemic changes at the small molecule and RNA transcript level.  
The first study discussed was designed to evaluate commonly used multivariate 
analysis techniques applied to metabolomics datasets (Chapter 6).  Metabolomics is a 
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rapidly growing field as the cost decreases and popularity increases.  Previous methods 
have been developed for transcriptomic and proteomic techniques in addition to other 
multivariate methods that have been applied towards metabolomics.  The diversity of 
methods, in addition to potentially conflicting results of alternate methods, necessitated 
an analysis that would facilitate the rapid comparison of multiple algorithms.  This would 
provide not only an objective means to identify the optimal algorithm but also facilitate 
more robust analyses by providing comprehensive results of multiple accepted methods.  
We therefore developed a new tool to rapidly assess algorithms for the analysis of 
metabolomics data.  The OmicsMarkeR program is an open-source package written for 
the extensive R Statistical Program
157
 and is made available through Bioconductor.  The 
results demonstrate how no algorithm is optimal for all problems as overall performance 
varies between datasets.  It is therefore important to compare and utilize multiple 
methods when exploring high-dimensional datasets such as metabolomics. 
The following study explored the impact of fed state upon the liver metabolic 
response to hemorrhagic shock and resuscitation (Chapter 7).  The objective was to 
determine if a carbohydrate prefeed would alter the liver metabolic processes following 
shock and if so, what processes were altered.  The results reported a clear distinction 
between fed and fasted animals via PLS-DA analysis.  The metabolites that contributed 
most towards the discrimination were associated with alternate carbon energy sources, 
amino acid metabolism, oxidative stress, and membrane maintenance.  This analysis 
revealed that carbohydrate prefeeding alters metabolic pathways during the response to 
shock and resuscitation. 
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Lastly, we conducted a transcriptomics analysis to evaluate the impact of fed state on 
gene expression following hemorrhagic shock and resuscitation (Chapter 8).  The 
objective was to determine if upstream metabolic pathways were altered at the gene 
expression level in response to a carbohydrate fed state.  Our findings reported changes in 
carbohydrate metabolism as expected but also changes in cytoskeleton reorganization and 
inflammation.  Our results and previous evidence in hypertonic resuscitation techniques 
suggest that the fasted state facilitates a shrunken, catabolic state of the liver cells 
providing an anti-inflammatory state that partially mitigates hepatocellular damage. 
This collective work demonstrates the application of high-throughput, systems level 
analysis to advance our understanding of the complex responses elicited by hemorrhagic 
shock and resuscitation.  We have successfully determined that fed state is an important 
consideration in hemorrhagic shock experiments thereby advancing upon a previous 
study that reported increased lung injury and a trend towards increased mortality in 
prefed pigs following hemorrhagic shock and resuscitation
155
.  These results provide a 
firm foundation from which future experiments in trauma should be expanded upon to 
include the fed state of the model organism.    Furthermore, the fed state could be readily 
determined through the early stages of shock via metabolomics and transcriptomics.  
However, this difference appears to dissipate in later stages likely a consequence of the 
metabolic effect of shock and injury overwhelming the metabolic effect of fed state.  This 
provides a potential opportunity to specifically treat patients in the early stages of shock 
that have eaten or not.  Transcriptomics results also provide further support for 
hypertonic resuscitation techniques.  These results suggest that by stimulating alternate 
conditions, it is theoretically possible to convert cells into a catabolic and anti-
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inflammatory state similar to ischemia precondition models.  Further research is needed 
to explore and advance fluid resuscitation techniques which should be guided by the 
inherent cellular processes. 
The integration of multiple levels of systems biology continues to be a difficult task.  
To our knowledge, there is no standard or recommended means to integrate these levels 
beyond correlations, mapping to pathways, and literature based knowledge of the 
biological processes.  Within our experiments, the limited number of metabolites 
resolved by NMR analysis renders any pathway analysis software unusable and therefore 
interpretations must be made with caution.  However, there were some consistencies 
between these two studies.  Altered carbohydrate metabolism was readily identified 
thereby confirming both methods were successful.  Additionally, indications of 
membrane maintenance that follow cytoskeletal remodeling and cellular shrinkage are 
potentially reflected by 3-Hydroxyisovalerate and sn-Glycero-3-phosphocholine (Chapter 
7).  The higher resolution of mass spectrometry analysis may provide further insights into 
the metabolome. 
This work has provided insight into the metabolomic and transcriptomic responses to 
hemorrhagic shock and resuscitation in addition to improving analytical methods.  
However, each of these components demonstrates the need for further research both 
within each specialty as well as integration methods.  Although we provide metabolomic 
and transcriptomic data, proteomics also provides invaluable information on the 
compounds conducting the processes involved.  Future work should also continue to 
develop improved algorithms with standardized means of evaluation.  An exploration of 
the impact of alternate diets is strongly encouraged following the clear discrimination 
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between carbohydrate prefed and fasted pigs at both the metabolomic and transcriptomic 
levels.  Furthermore, this work suggests a renewed interest in the ‘metabolic state’ of 
cells whereby different conditions poise a cell to respond to a stimulus in a different and 
potentially beneficial manner.  Finally, methodology in systems biology integration needs 
to be more readily accessible.  This is rapidly becoming possible as costs continue to drop 
through advancements in next-generation and high-throughput technologies.  The 
movement beyond the classical biological dogma, wherein each component is considered 
separately, towards an integrative and holistic perspective will advance our understanding 
of not only the complex processes following hemorrhagic shock and resuscitation but 
other systemic pathologies as well. 
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Figure 1:  Graphical representation of the experimental timeline described in Methods. 
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NMR – BINARY - HIGH SAMPLE 
Non-Ensemble 
 Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.466 0.497 0.423 0.196 0.597 0.621 0.460 0.366 0.422 0.213 0.552 0.528 
Accuracy 0.436 0.590 0.780 0.880 0.740 0.750 0.460 0.530 0.660 0.940 0.670 0.660 
AUC-
ROC 
0.597 0.781 0.892 0.956 0.876 0.806 0.779 0.787 0.824 0.984 0.856 0.751 
Stability 0.50 0.43 0.29 0.11 0.50 0.53 0.46 0.28 0.31 0.12 0.47 0.44 
 
Ensemble 
 Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.462 0.493 0.424 0.405 0.478 0.617 0.441 0.374 0.477 0.315 0.557 0.510 
Accuracy 0.445 0.530 0.720 0.920 0.710 0.780 0.432 0.470 0.670 0.920 0.520 0.650 
AUC-
ROC 
0.648 0.765 0.884 0.960 0.884 0.783 0.593 0.870 0.816 0.980 0.708 0.769 
Stability 0.48 0.46 0.30 0.26 0.36 0.51 0.45 0.31 0.37 0.19 0.60 0.42 
 
Table 1 – Results from High Sample (50/group) NMR-scale Binary Null Classification Simulations.  RPT – Robustness-Performance Trade-off, AUC-
ROC – Area under the Receiver Operator Curve 
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NMR – BINARY - LOW SAMPLE 
Non-Ensemble 
  Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.411 0.432 0.395 0.212 0.569 0.562 0.455 0.422 0.525 0.227 0.596 0.578 
Accuracy 0.365 0.425 0.825 0.900 0.775 0.700 0.410 0.425 0.850 0.900 0.650 0.750 
AUC-
ROC 
0.565 0.663 0.925 0.975 0.900 0.806 0.603 0.706 0.900 0.975 0.900 0.831 
Stability 0.47 0.44 0.26 0.12 0.45 0.47 0.51 0.42 0.38 0.13 0.55 0.47 
  
Ensemble 
  Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.386 0.457 0.558 0.357 0.530 0.525 0.442 0.502 0.525 0.355 0.570 0.434 
Accuracy 0.365 0.475 0.875 0.950 0.875 0.700 0.410 0.675 0.675 0.925 0.750 0.600 
AUC-
ROC 
0.565 0.713 0.950 1.000 0.950 0.894 0.603 0.681 0.900 1.000 0.925 0.744 
Stability 0.41 0.44 0.41 0.22 0.38 0.42 0.48 0.40 0.43 0.22 0.46 0.34 
 
Table 2 – Results from Low Sample (25/group) NMR-scale Binary Null Classification Simulations.  RPT – Robustness-Performance Trade-off, AUC-
ROC – Area under the Receiver Operator Curve 
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NMR – MULTI-CLASS - HIGH SAMPLE 
Non-Ensemble 
 Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.357 0.340 0.418 0.211 0.462 0.462 0.299 0.342 0.460 0.211 0.432 0.466 
Accuracy 0.262 0.315 0.390 0.875 0.410 0.430 0.238 0.280 0.470 0.870 0.415 0.445 
AUC-
ROC 0.657 0.683 0.763 0.964 0.757 0.736 0.645 0.714 0.751 0.967 0.713 0.688 
Stability 0.56 0.37 0.45 0.12 0.53 0.50 0.40 0.44 0.45 0.12 0.45 0.49 
 
Ensemble 
 Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.347 0.392 0.418 0.269 0.397 0.443 0.317 0.280 0.428 0.256 0.444 0.436 
Accuracy 0.258 0.360 0.390 0.850 0.385 0.405 0.241 0.205 0.460 0.880 0.335 0.400 
AUC-
ROC 0.589 0.672 0.764 0.921 0.735 0.696 0.653 0.665 0.740 0.937 0.741 0.714 
Stability 0.53 0.43 0.45 0.16 0.41 0.49 0.46 0.44 0.40 0.15 0.66 0.48 
 
Table 3 – Results from High Sample (50/group) NMR-scale Multi-Class Null Classification Simulations.  RPT – Robustness-Performance Trade-off, 
AUC-ROC – Area under the Receiver Operator Curve 
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NMR – MULTI-CLASS - LOW SAMPLE 
Non-Ensemble 
  Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.336 0.350 0.399 0.212 0.518 0.524 0.351 0.280 0.439 0.228 0.472 0.571 
Accuracy 0.250 0.300 0.638 0.925 0.550 0.563 0.306 0.225 0.563 0.913 0.538 0.538 
AUC-
ROC 0.647 0.723 0.913 0.963 0.871 0.817 0.598 0.722 0.838 0.992 0.796 0.772 
Stability 0.51 0.42 0.29 0.12 0.49 0.49 0.41 0.37 0.36 0.13 0.42 0.61 
  
Ensemble 
  Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.271 0.329 0.480 0.227 0.403 0.460 0.347 0.359 0.548 0.227 0.551 0.585 
Accuracy 0.263 0.275 0.600 0.900 0.475 0.450 0.306 0.325 0.700 0.888 0.525 0.600 
AUC-
ROC 0.733 0.782 0.858 0.954 0.804 0.741 0.598 0.749 0.850 0.967 0.800 0.794 
Stability 0.28 0.41 0.40 0.13 0.35 0.47 0.40 0.40 0.45 0.13 0.58 0.57 
 
Table 4 – Results from Low Sample (25/group) NMR-scale Multi-Class Null Classification Simulations.  RPT – Robustness-Performance Trade-off, 
AUC-ROC – Area under the Receiver Operator Curve 
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MS – BINARY - HIGH SAMPLE 
Non-Ensemble 
 Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.367 0.370 0.181 0.077 0.428 0.448 0.372 0.297 0.241 0.058 0.450 0.462 
Accuracy 0.500 0.590 0.940 0.940 0.820 0.810 0.520 0.420 0.860 0.880 0.820 0.770 
AUC-
ROC 0.580 0.805 0.964 0.952 0.892 0.891 0.580 0.809 0.952 0.924 0.984 0.808 
Stability 0.29 0.27 0.10 0.04 0.29 0.31 0.29 0.23 0.14 0.03 0.31 0.33 
 
Ensemble 
 Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.324 0.391 0.400 0.257 0.413 0.355 0.338 0.326 0.487 0.297 0.385 0.406 
Accuracy 0.500 0.560 0.870 0.900 0.880 0.78 0.52 0.39 0.86 0.85 0.84 0.74 
AUC-
ROC 0.580 0.755 0.980 0.968 0.968 0.872 0.580 0.793 0.984 0.956 0.924 0.865 
Stability 0.24 0.30 0.26 0.15 0.27 0.23 0.25 0.28 0.34 0.18 0.25 0.28 
 
Table 5 – Results from High Sample (50/group) MS-scale Binary Null Classification Simulations.  RPT – Robustness-Performance Trade-off, AUC-
ROC – Area under the Receiver Operator Curve 
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MS – BINARY - LOW SAMPLE 
Non-Ensemble 
  Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.339 0.308 0.368 0.058 0.568 0.554 0.393 0.286 0.357 0.077 0.543 0.514 
Accuracy 0.295 0.400 0.925 0.850 0.925 0.900 0.465 0.450 0.950 0.875 0.950 0.900 
AUC-
ROC 0.549 0.731 1.000 0.975 1.000 0.831 0.566 0.731 1.000 0.975 1.000 0.925 
Stability 0.40 0.25 0.23 0.03 0.41 0.40 0.34 0.21 0.22 0.04 0.38 0.36 
  
Ensemble 
  Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.312 0.460 0.563 0.366 0.553 0.494 0.386 0.352 0.479 0.318 0.453 0.450 
Accuracy 0.295 0.525 0.900 0.900 0.950 0.900 0.465 0.475 0.875 0.975 0.925 0.900 
AUC-
ROC 0.549 0.825 0.950 1.000 1.000 0.919 0.566 0.719 0.975 1.000 1.000 0.900 
Stability 0.33 0.41 0.41 0.23 0.39 0.34 0.33 0.28 0.33 0.19 0.30 0.30 
 
Table 6 – Results from Low Sample (25/group) MS-scale Binary Null Classification Simulations.  RPT – Robustness-Performance Trade-off, AUC-
ROC – Area under the Receiver Operator Curve 
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MS – MULTI-CLASS - HIGH SAMPLE 
Non-Ensemble 
 Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.249 0.238 0.206 0.039 0.421 0.415 0.313 0.240 0.191 0.020 0.368 0.421 
Accuracy 0.193 0.260 0.730 0.910 0.580 0.590 0.328 0.300 0.720 0.860 0.580 0.580 
AUC-
ROC 0.669 0.686 0.885 0.983 0.804 0.711 0.777 0.695 0.877 0.945 0.830 0.736 
Stability 0.35 0.22 0.12 0.02 0.33 0.32 0.30 0.20 0.11 0.01 0.27 0.33 
 
Ensemble 
 Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.191 0.282 0.371 0.225 0.376 0.324 0.338 0.326 0.487 0.297 0.385 0.406 
Accuracy 0.238 0.285 0.645 0.840 0.535 0.500 0.520 0.390 0.860 0.850 0.840 0.740 
AUC-
ROC 0.659 0.683 0.834 0.899 0.775 0.715 0.580 0.793 0.984 0.956 0.924 0.865 
Stability 0.16 0.28 0.26 0.13 0.29 0.24 0.25 0.28 0.34 0.18 0.25 0.28 
 
Table 7 – Results from High Sample (50/group) MS-scale Multi-Class Null Classification Simulations.  RPT – Robustness-Performance Trade-off, 
AUC-ROC – Area under the Receiver Operator Curve 
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MS – MULTI-CLASS - LOW SAMPLE 
Non-Ensemble 
  Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.270 0.234 0.299 0.039 0.545 0.513 0.285 0.245 0.286 0.039 0.494 0.540 
Accuracy 0.213 0.288 0.875 0.888 0.812 0.750 0.231 0.263 0.900 0.938 0.788 0.700 
AUC-
ROC 0.726 0.804 0.954 0.967 0.913 0.827 0.630 0.689 0.958 0.996 0.913 0.769 
Stability 0.37 0.28 0.18 0.02 0.41 0.39 0.37 0.23 0.17 0.02 0.36 0.44 
  
Ensemble 
  Random Correlated 
Method PLSDA GBM SVM RF GLMNET PAM PLSDA GBM SVM RF GLMNET PAM 
RPT 0.160 0.308 0.465 0.302 0.501 0.434 0.174 0.290 0.588 0.259 0.463 0.435 
Accuracy 0.188 0.275 0.850 0.938 0.775 0.725 0.206 0.300 0.888 0.950 0.725 0.575 
AUC-
ROC 0.737 0.774 0.963 0.996 0.913 0.709 0.770 0.715 0.988 0.967 0.846 0.790 
Stability 0.14 0.35 0.32 0.18 0.37 0.31 0.15 0.28 0.44 0.15 0.34 0.35 
 
Table 8 – Results from Low Sample (25/group) MS-scale Multi-Class Null Classification Simulations.  RPT – Robustness-Performance Trade-off, 
AUC-ROC – Area under the Receiver Operator Curve 
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MS - BINARY – DISCRIMINATORY - HIGH SAMPLE 
Subset 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.681 0.484 0.630 0.302 0.718 0.746 
Accuracy 0.770 0.570 1.000 0.940 1.000 0.960 
AUC-ROC 0.602 0.784 1.000 0.880 1.000 0.939 
Stability 0.61 0.42 0.46 0.18 0.56 0.61 
Max # Features 20 20 20 20 20 20 
TP % 65.0% 54.0% 52.0% 38.5% 64.5% 62.0% 
    
Model Derived 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.655 0.514 0.598 0.182 0.649 0.857 
Accuracy 0.810 0.600 0.980 0.990 1.000 1.000 
AUC-ROC 0.849 0.770 1.000 1.000 1.000 1.000 
Stability 0.55 0.45 0.43 0.10 0.48 0.75 
Max # Features 285 23 100 126 83 800 
TP % 6.7% 47.4% 15.7% 9.0% 19.6% 2.5% 
    
Ensemble 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.681 0.525 0.630 0.305 0.718 0.746 
Accuracy 0.770 0.650 1.000 1.000 1.000 0.960 
AUC-ROC 0.602 0.846 1.000 1.000 1.000 0.939 
Stability 0.61 0.44 0.46 0.18 0.56 0.61 
Max # Features 20 20 20 20 20 20 
TP % 66.5% 54.5% 52.0% 41.5% 64.5% 62.0% 
 
Table 9 – Results from High Sample (50/group) MS-scale Binary Classification Simulations.  RPT – 
Robustness-Performance Trade-off, AUC-ROC – Area under the Receiver Operator Curve 
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MS - BINARY – DISCRIMINATORY - LOW SAMPLE 
Subset 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.429 0.336 0.435 0.113 0.573 0.655 
Accuracy 0.410 0.475 0.975 0.975 0.950 0.950 
AUC-ROC 0.552 0.794 1.000 1.000 0.950 0.925 
Stability 0.45 0.26 0.28 0.06 0.41 0.50 
Max # Features 20 20 20 20 20 20 
TP % 33.0% 22.0% 20.0% 10.5% 32.5% 25.5% 
    
Model Derived 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.492 0.292 0.614 0.112 0.670 0.874 
Accuracy 0.413 0.400 0.925 0.825 0.975 0.950 
AUC-ROC 0.700 0.713 0.975 0.950 1.000 0.925 
Stability 0.61 0.23 0.46 0.06 0.51 0.81 
Max # Features 325 85 100 68 67 881 
TP % 4.1% 8.9% 9.6% 4.9% 13.6% 2.1% 
    
Ensemble 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.394 0.480 0.601 0.433 0.563 0.582 
Accuracy 0.410 0.625 1.000 0.950 0.950 0.950 
AUC-ROC 0.552 0.663 1.000 1.000 0.975 0.925 
Stability 0.38 0.39 0.43 0.28 0.40 0.42 
Max # Features 20 20 20 20 20 20 
TP % 31.0% 28.0% 25.0% 23.5% 33.0% 28.0% 
 
Table 10 – Results from Low Sample (25/group) MS-scale Binary Classification Simulations.  RPT – 
Robustness-Performance Trade-off, AUC-ROC – Area under the Receiver Operator Curve 
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MS - MULTI-CLASS - DISCRIMINATORY - HIGH SAMPLE 
Subset 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.462 0.246 0.495 0.147 0.666 0.581 
Accuracy 0.380 0.180 0.845 0.930 0.800 0.735 
AUC-ROC 0.723 0.698 0.957 0.985 0.938 0.753 
Stability 0.59 0.39 0.35 0.08 0.57 0.48 
Max # Features 20 20 20 20 20 20 
TP % 57.0% 42.5% 47.5% 24.0% 53.0% 53.0% 
    
Model Derived 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.475 0.208 0.547 0.244 0.655 0.931 
Accuracy 0.402 0.165 0.915 0.950 0.950 0.895 
AUC-ROC 0.698 0.651 0.959 0.991 0.994 0.770 
Stability 0.58 0.28 0.39 0.14 0.50 0.97 
Max # Features 357 207 100 252 226 991 
TP % 4.7% 6.7% 14.7% 3.7% 6.4% 2.0% 
    
Ensemble 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.393 0.351 0.626 0.587 0.636 0.603 
Accuracy 0.370 0.280 0.865 0.925 0.795 0.760 
AUC-ROC 0.618 0.639 0.979 0.977 0.920 0.768 
Stability 0.42 0.47 0.49 0.43 0.53 0.50 
Max # Features 20 20 20 20 20 20 
TP % 55.5% 47.5% 55.5% 53.5% 55.5% 53.5% 
 
Table 11 – Results from High Sample (50/group) MS-scale Multi-Class Classification Simulations.  RPT – 
Robustness-Performance Trade-off, AUC-ROC – Area under the Receiver Operator Curve 
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MS - MULTI-CLASS - DISCRIMINATORY - LOW SAMPLE 
Subset 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.378 0.131 0.352 0.113 0.568 0.618 
Accuracy 0.294 0.088 0.875 0.900 0.800 0.763 
AUC-ROC 0.721 0.728 0.975 0.979 0.963 0.704 
Stability 0.53 0.26 0.22 0.06 0.44 0.52 
Max # Features 20 20 20 20 20 20 
TP % 45.5% 18.0% 27.0% 14.0% 34.0% 38.5% 
    
Model Derived 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.424 0.253 0.631 0.164 0.661 0.918 
Accuracy 0.317 0.238 0.888 0.913 0.938 0.863 
AUC-ROC 0.701 0.767 0.954 0.975 1.000 0.844 
Stability 0.64 0.27 0.49 0.09 0.51 0.98 
Max # Features 382 191 100 159 108 989 
TP % 3.4% 4.6% 10.1% 4.1% 7.9% 2.0% 
    
Ensemble 
Method PLSDA GBM SVM RF GLMNET PAM 
RPT 0.306 0.222 0.629 0.414 0.600 0.585 
Accuracy 0.313 0.163 0.913 0.888 0.800 0.725 
AUC-ROC 0.668 0.756 0.992 1.000 0.971 0.736 
Stability 0.30 0.35 0.48 0.27 0.48 0.49 
Max # Features 20 20 20 20 20 20 
TP % 34.0% 27.5% 33.0% 30.5% 29.5% 38.0% 
 
Table 12 – Results from Low Sample (25/group) MS-scale Multi-Class Classification Simulations.  RPT – 
Robustness-Performance Trade-off, AUC-ROC – Area under the Receiver Operator Curve 
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Eisner Results 
Non-ensemble Results 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .657 .430 .457 .331 .705 .711 
Accuracy  .757 .557 .871 .957 .786 .771 
AUC-ROC .685 .773 .933 .975 .958 .744 
Stability  .58 .35 .31 .20 .64 .66 
Table 13 - Non-ensemble model diagnostics of Eisner dataset 
 
 
Output from feature.table 
 
PAM Feature Table 
features consistency frequency 
Adipate 10 1 
Creatine 10 1 
Glucose 10 1 
Succinate 10 1 
X3.Hydroxyisovalerate 10 1 
myo.Inositol 9 0.9 
Betaine 7 0.7 
Glutamine 7 0.7 
Quinolinate 6 0.6 
cis.Aconitate 6 0.6 
Acetate 5 0.5 
N.N.Dimethylglycine 5 0.5 
Lysine 3 0.3 
Leucine 2 0.2 
Table 14 – Eisner PAM feature table 
 
 
 
 
 
GLMNET Feature Table 
features consistency frequency 
Adipate 10 1 
Glucose 10 1 
Leucine 10 1 
Quinolinate 10 1 
Valine 10 1 
X3.Hydroxyisovalerate 10 1 
myo.Inositol 9 0.9 
Succinate 6 0.6 
Betaine 4 0.4 
Glutamine 4 0.4 
Lysine 4 0.4 
Creatine 3 0.3 
N.N.Dimethylglycine 3 0.3 
Acetate 3 0.3 
Alanine 2 0.2 
Formate 1 0.1 
Xylose 1 0.1 
Table 15 – Eisner GLMNET feature table 
 
  
143 
 
Ensemble Results 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .696 .486 .612 .433 .572 .721 
Accuracy  .736 .529 .743 .957 .686 .743 
AUC-ROC .802 .717 .892 1.0 .967 .790 
Stability  .66 .45 .52 .28 .49 .70 
Table 16 - Ensemble model diagnostics of Eisner dataset 
Output from feature.table 
PAM Feature Table 
features consistency frequency 
Adipate 10 1 
Creatine 10 1 
Glucose 10 1 
Succinate 10 1 
X3.Hydroxyisovalerate 10 1 
myo.Inositol 9 0.9 
N.N.Dimethylglycine 9 0.9 
Quinolinate 9 0.9 
Acetate 7 0.7 
Glutamine 5 0.5 
Betaine 3 0.3 
Leucine 2 0.2 
Sucrose 2 0.2 
cis.Aconitate 2 0.2 
X3.Hydroxybutyrate 1 0.1 
Alanine 1 0.1 
Table 17 – Eisner PAM ensemble feature 
table 
 
 
 
 
 
 
 
 
 
PLSDA Feature Table 
features consistency frequency 
Glucose 10 1 
Leucine 10 1 
Quinolinate 10 1 
Valine 10 1 
X3.Hydroxyisovalerate 10 1 
Adipate 9 0.9 
Succinate 9 0.9 
myo.Inositol 7 0.7 
N.N.Dimethylglycine 7 0.7 
Creatine 5 0.5 
Glutamine 4 0.4 
X3.Hydroxybutyrate 2 0.2 
Betaine 2 0.2 
Methylamine 1 0.1 
Alanine 1 0.1 
Pyroglutamate 1 0.1 
Acetate 1 0.1 
Formate 1 0.1 
Table 18 – Eisner GLMNET ensemble 
feature table 
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Ametaj Results 
Non-ensemble Results 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .597 .327 .711 .383 .806 .850 
Accuracy  .488 .300 .975 .950 .900 .850 
AUC-ROC .775 .796 1.0 1.0 1.0 .875 
Stability  .77 .39 .56 .24 .73 .85 
Table 19 - Non-ensemble model diagnostics of Ametaj dataset 
Output from feature.table() 
PAM Feature Table 
features consistency frequency 
Alanine 10 1 
Dimethylamine 10 1 
Endotoxin 10 1 
Ferulate 10 1 
Fumarate 10 1 
Glucose 10 1 
Methylamine 10 1 
Uracil 10 1 
Xanthine 8 0.8 
Lactate 7 0.7 
Lysine 3 0.3 
Propionate 1 0.1 
Valerate 1 0.1 
Table 20 – Ametaj PAM Feature Table 
GLMNET Feature Table 
features consistency frequency 
Acetate 10 1 
Endotoxin 10 1 
Glucose 10 1 
Lactate 10 1 
Methylamine 10 1 
Propionate 10 1 
Uracil 10 1 
Lysine 7 0.7 
Phenylacetate 7 0.7 
Butyrate 5 0.5 
Dimethylamine 4 0.4 
Alanine 3 0.3 
Xanthine 2 0.2 
Isoleucine 1 0.1 
X3.PP 1 0.1 
Table 21 – Ametaj GLMNET Table 
 
PLSDA Feature Table 
features consistency frequency 
Acetate 10 1 
Glucose 10 1 
Isoleucine 10 1 
Lactate 10 1 
Methylamine 10 1 
Benzoate 9 0.9 
Endotoxin 9 0.9 
Fumarate 9 0.9 
Aspartate 8 0.8 
Ferulate 7 0.7 
Alanine 3 0.3 
Dimethylamine 2 0.2 
X3.PP 1 0.1 
Butyrate 1 0.1 
Propionate 1 0.1 
Table 22 – Ametaj PLSDA Feature Table 
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Ensemble Results 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .575 .364 .813 .638 .813 .825 
Accuracy  .438 .250 .950 .950 .950 .875 
AUC-ROC .779 .750 1.0 1.0 1.0 .892 
Stability  .84 .67 .71 .48 .71 .78 
Table 23 - Ensemble model diagnostics of Ametaj dataset 
Output from feature.table 
PAM Feature Table 
features consistency frequency 
Alanine 10 1 
Dimethylamine 10 1 
Endotoxin 10 1 
Ferulate 10 1 
Fumarate 10 1 
Glucose 10 1 
Methylamine 10 1 
Uracil 10 1 
NDMA 6 0.6 
Lactate 5 0.5 
Propionate 3 0.3 
Hypoxanthine 3 0.3 
Xanthine 2 0.2 
Glycerol 1 0.1 
Table 24 – Ametaj PAM Ensemble Table 
SVM Feature Table 
features consistency frequency 
Endotoxin 10 1 
Formate 10 1 
Glucose 10 1 
Methylamine 10 1 
Uracil 10 1 
Ferulate 9 0.9 
Fumarate 8 0.8 
Histidine 8 0.8 
X3.HP 7 0.7 
Isovalerate 6 0.6 
Maltose 6 0.6 
X1.3.D 3 0.3 
Dimethylamine 2 0.2 
X3.PP 1 0.1 
Table 25 – Ametaj SVM Ensemble Table 
 
 
 
PLSDA Feature Table 
features consistency frequency 
Alanine 10 1 
Dimethylamine 10 1 
Endotoxin 10 1 
Glucose 10 1 
Methylamine 10 1 
Uracil 10 1 
Valine 10 1 
Leucine 9 0.9 
NDMA 9 0.9 
Glycerol 7 0.7 
Propionate 2 0.2 
Cadaverine 2 0.2 
Xanthine 1 0.1 
Table 26 – Ametaj PLSDA Ensemble Table 
GLMNET Feature Table 
features consistency frequency 
Acetate 10 1 
Alanine 10 1 
Butyrate 10 1 
Isovalerate 10 1 
X3.HP 10 1 
X3.PP 10 1 
Propionate 9 0.9 
Benzoate 7 0.7 
Phenylacetate 7 0.7 
Lysine 7 0.7 
Isoleucine 3 0.3 
X3.HB 2 0.2 
Glucose 1 0.1 
X1.3.D 1 0.1 
Endotoxin 1 0.1 
Isobutyrate 1 0.1 
Lactate 1 0.1 
Table 27 – Ametaj GLMNET Ensemble Table
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Xiao Results 
Negative Mode 
1fv2f 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .579 .298 .481 .163 .606 .679 
Accuracy  .589 .511 .889 .889 .822 .678 
AUC-ROC .597 .608 .855 .865 .835 .610 
Stability  .57 .21 .33 .09 .48 .68 
Table 28 – Xiao Negative 1fv2f Model Diagnostics 
 
1fv2r 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .536 .224 .390 .180 .626 .662 
Accuracy  .607 .444 .889 .900 .867 .644 
AUC-ROC .578 .645 .805 .870 .885 .603 
Stability  .48 .15 .25 .10 .49 .68 
Table 29 – Xiao Negative 1fv2r Model Diagnostics 
 
1rv2f 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .635 .258 .514 .197 .680 .679 
Accuracy  .663 .456 .967 .933 .867 .678 
AUC-ROC .622 .659 .950 .925 .865 .724 
Stability  .61 .18 .35 .11 .56 .68 
Table 30 – Xiao Negative 1rv2f Model Diagnostics 
 
1rv2r 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .665 .294 .455 .229 .665 .746 
Accuracy  .650 .444 .944 .956 .867 .733 
AUC-ROC .590 .625 .920 .915 .855 .681 
Stability  .68 .22 .30 .13 .54 .76 
Table 31 – Xiao Negative 1rv2r Model Diagnostics 
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Positive Mode 
 
1fv2f 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .453 .267 .574 .147 .646 .643 
Accuracy  .522 .300 .956 .900 .911 .667 
AUC-ROC .625 .651 .895 .855 .865 .605 
Stability  .40 .24 .41 .08 .50 .62 
Table 32 – Xiao Positive 1fv2f Model Diagnostics 
 
1fv2r 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .495 .266 .548 .164 .612 .610 
Accuracy  .583 .444 .922 .922 .844 .656 
AUC-ROC .659 .645 .805 .845 .830 .660 
Stability  .43 .19 .39 .09 .48 .57 
Table 33 – Xiao Positive 1fv2r Model Diagnostics 
 
1rv2f 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .546 .298 .600 .164 .686 .658 
Accuracy  .633 .511 .944 .922 .911 .656 
AUC-ROC .660 .600 .925 .910 .930 .6625 
Stability  .48 .21 .44 .09 .55 .66 
Table 34 – Xiao Positive 1rv2f Model Diagnostics 
 
1rv2r 
 PLSDA  GBM  SVM  RF  GLMNET  PAM  
RPT  .573 .403 .560 .181 .694 .737 
Accuracy  .637 .544 .933 .933 .911 .733 
AUC-ROC .562 .614 .930 .905 .905 .688 
Stability  .52 .32 .40 .10 .56 .74 
Table 35 – Xiao Positive 1rv2r Model Diagnostics 
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Number Features Identified 
PAM 
Mode Comparison # Ions Selected 
Positive 1F v. 2F 157 
Positive 1F v. 2R 154 
Positive 1R v. 2F 154 
Positive 1R v. 2R 136 
Negative 1F v. 2F 100 
Negative 1F v. 2R 104 
Negative 1R v. 2F 86 
Negative 1R v. 2R 74 
Table 36 – Xiao PAM Number of Features Identified by Comparison 
 
GLMNET 
Mode Comparison # Ions Selected 
Positive 1F v. 2F 191 
Positive 1F v. 2R 177 
Positive 1R v. 2F 189 
Positive 1R v. 2R 185 
Negative 1F v. 2F 153 
Negative 1F v. 2R 136 
Negative 1R v. 2F 113 
Negative 1R v. 2R 114 
Table 37 – Xiao GLMNET Number of Features Identified by Comparison 
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Response to Shock (S45-B) VIP Scores 
Metabolite VIP Score Metabolite VIP Score 
Glucose 3.301 Hypoxanthine 0.338 
Lactate 2.237 Nacinamide 0.334 
Aspartate 2.042 Betaine 0.332 
Maltose 1.993 Pyruvate 0.319 
Sucrose 1.967 Histidine 0.317 
Glutathione 1.4122 Glycine 0.290 
Xanthine 1.391 Lysine 0.264 
Asparagine 1.375 Leucine 0.214 
Adenosine 1.296 NADP 0.196 
3-Hydroxyisovalerate 1.257 3-Aminoisobutyrate 0.161 
O-Phosphocholine 1.173 Tyrosine 0.091 
Sn-Glycero-3-phosphocholine 1.162 Glutamine 0.078 
Fumarate 1.087 Choline 0.076 
Succinate 1.052 Creatine 0.072 
Valine 0.997 ATP 0.063 
Dimethylamine 0.927 Isovalerate 0.047 
AMP 0.876 Acetate 0.027 
Isoleucine 0.811 Proline 0.026 
Glutamate 0.785 UDP-Glucose 0.012 
3-Hydroxybutyrate 0.764   
Serine 0.702   
Citrate 0.631   
Phenylalanine 0.626   
Alanine 0.621   
Arginine 0.5852   
Taurine 0.555   
Methionine 0.5476   
ADP 0.537   
Formate 0.4947   
Creatinine 0.489   
Benzoate 0.414   
NAD 0.352   
Table 1 - Complete Metabolite VIP Scores during the response to shock (S45-B) comparing 
Fasted and Carbohydrate Prefed pigs. 
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Response to Resuscitation (FR2-S45) VIP Scores 
Metabolite VIP Score Metabolite VIP Score 
Glucose 3.311 Hypoxanthine 0.388 
3-Hydroxyisovalerate 2.083 3-Aminoisobutyrate 0.325 
Valine 1.659 Xanthine 0.318 
Fumarate 1.658 Tyrosine 0.294 
Benzoate 1.639 Sucrose 0.270 
Leucine 1.590 Glycine 0.268 
Choline 1.367 Succinate 0.258 
Isoleucine 1.364 Taurine 0.2534 
Lysine 1.356 Maltose 0.242 
Sn-Glycero-3-Phosphocholine 1.355 ATP 0.238 
Arginine 1.309 Asparagine 0.207 
Niacinamide 1.306 Histidine 0.190 
Adenosine 1.242 3-Hydroxybutyrate 0.168 
Aspartate 1.111 Glutamate 0.157 
Formate 1.0754 Betaine 0.152 
Alanine 0.998 Phenylalanine 0.150 
Proline 0.938 Dimethylamine 0.121 
Serine 0.896 Isovalerate 0.036 
Creatine 0.835 AMP 0.020 
O-Phosphocholine 0.808   
Glutathione 0.802   
Glutamine 0.779   
NADP 0.763   
NAD 0.722   
Creatinine 0.688   
Citrate 0.687   
Lactate 0.637   
Acetate 0.606   
UDP-Glucose 0.600   
ADP 0.5906   
Pyruvate 0.467   
Methionine 0.418   
Table 2 - Complete Metabolite VIP Scores during the response to resuscitation (FR2-S45) 
comparing Fasted and Carbohydrate Prefed pig 
 
 
